
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/14/2022</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Carel Industries rises for a third consecutive year</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Charles River Laboratories : J.P. Morgan Healthcare Conference Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">MARKET ANALYSIS / MANAGEMENT / CAPITALIZATION / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tycho W. Peterson / Mr. Casey Woodring / Julia Qin / Ms. Rachel M. Vatnsdal / Noah J. Burhance</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Important Update (+ New Model) – Notes from the Road – JPM Conference</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Thoughts on Initial 2022 Guidance and Announced CFO Transition</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III / Justin Lin / Christine Rains</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Charles River Laboratories : 2022 Guidance Pre-Announced - ALERT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">MARKET ANALYSIS / MANAGEMENT / CAPITALIZATION / MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tycho W. Peterson / Mr. Casey Woodring / Julia Qin / Ms. Rachel M. Vatnsdal / Noah J. Burhance</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">CFO David Smith to Retire (Smooth Transition); '22 Org Revs, EPS & CapEx Above S</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Stephens Inc.</td><td class="leftalignment">Mid-Day Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">CI / CNC / DAR / HUM / THC.N / UHS.N / UNH.N / HCA.N / WST.N / 2047317 / 2274922 / 2158781 / 2222471 / 2604336 / 2380863 / 2437264 / 2501578 / 2567655 / 2731654 / 2733092 / 2774336 / 2909730 / FAST.O / FCFS.O / 2788713 / 2212706 / ANTM.K / 2598246 / B11FJD6 / CDXS.O / LMNR.O / 2318790 / B1YWPP8 / B4N8MH9 / CYRX.O / BLFS.O / B7K24P7 / BF23JJ3 / REPH.O / CTLT.K / CIVB.O / MIME.OQ / OKTA.O / CDMO.O / SAIL.K / AVNS.N / ALCC.S / CRWD.O / CYBG.F / NCNO.O / BSHZ3Q0 / BLFGN66 / BLFGN99 / BKT6B49 / BP7L561 / BKMQF66 / BMVWBY9</td><td class="leftalignment">Cigna Corp / Centene Corp / Darling Ingredients Inc / Humana Inc / Tenet Healthcare Corp / Universal Health Services Inc / UnitedHealth Group Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Archer-Daniels-Midland Co / Andersons Inc / Cal-Maine Foods Inc / Cerus Corp / Charles River Laboratories International Inc / W W Grainger Inc / Hormel Foods Corp / Ligand Pharmaceuticals Inc / MSC Industrial Direct Co Inc / Repligen Corp / Rent-A-Center Inc / Sanderson Farms Inc / Tyson Foods Inc / Fastenal Co / Firstcash Holdings Inc / Bunge Ltd / Molina Healthcare Inc / Anthem Inc / Neogenomics Inc / Green Plains Inc / Codexis Inc / Limoneira Co / OraSure Technologies Inc / Ensign Group Inc / Pacific Biosciences of California Inc / Cryoport Inc / BioLife Solutions Inc / Ingredion Inc / Re/Max Holdings Inc / Recro Pharma Inc / Catalent Inc / Civista Bancshares Inc / Mimecast Ltd / Okta Inc / Avid Bioservices Inc / SailPoint Technologies Holdings Inc / Avanos Medical Inc / Alcon AG / CrowdStrike Holdings Inc / Cyberark Software Ltd / nCino Inc / Bio-Techne Corp / PROG Holdings Inc / Aaron's Company Inc / Ping Identity Holding Corp / Alpha Teknova Inc / MaxCyte Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Stephens Research</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Stephens Inc.</td><td class="leftalignment">Weekly Reader: AZTA, BLFS, CDXS, CTLT, OSUR, TECH, TKNO</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BLFS.OQ / CDXS.OQ / CTLT.N / OSUR.OQ / TECH.OQ / TKNO.OQ / WST.N / 2222471 / 2604336 / 2501578 / 2731654 / 2598246 / CDXS.O / 2318790 / B4N8MH9 / CYRX.O / BLFS.O / REPH.O / CTLT.K / CDMO.O / BSHZ3Q0 / BP7L561 / BKMQF66</td><td class="leftalignment">BioLife Solutions Inc / Codexis Inc / Catalent Inc / OraSure Technologies Inc / Bio-Techne Corp / Alpha Teknova Inc / West Pharmaceutical Services Inc / Cerus Corp / Charles River Laboratories International Inc / Ligand Pharmaceuticals Inc / Repligen Corp / Neogenomics Inc / Codexis Inc / OraSure Technologies Inc / Pacific Biosciences of California Inc / Cryoport Inc / BioLife Solutions Inc / Recro Pharma Inc / Catalent Inc / Avid Bioservices Inc / Bio-Techne Corp / Alpha Teknova Inc / MaxCyte Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Jacob Johnson, CFA / Steven Etoch</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">284</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Carel Industries SpA</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment"></td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - New report: Biotech funding growth does not appear to be a good indicator of CXO revenue growth</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LONN.S / CRL.N / ICLR.OQ / 2269.HK</td><td class="leftalignment">Lonza Group AG / Charles River Laboratories International Inc / ICON PLC / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: Biotech funding growth does not appear to be a good indicator of CXO revenue growth</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LONN.S / CRL.N / ICLR.OQ / MRNA.OQ / EDIT.OQ / 2269.HK</td><td class="leftalignment">Lonza Group AG / Charles River Laboratories International Inc / ICON PLC / Moderna Inc / Editas Medicine Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Life Science Tools & Dx : Questions & Themes for J.P. Morgan Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">106</td><td class="leftalignment">A.N / ADPT.O / TMO.N / WAT.N / DGX.N / DHR.N / ICLR.O / LH.N / MTD.N / XRAY.O / PKI.N / MYGN.O / ILMN.O / ISRG.O / CRL.N / HOLX.O / QDEL.O / BRKR.O / QGEN.N / PACB.O / AXDX.O / NSTG.O / CTLT.N / NVTA.N / NTRA.O / QTRX.O / SYNH.O / GH.O / TWST.O / AVTR.N / NVST.N / TXG.O / RNLX.O / SHC.O / SEER.O / OCDX.O / ZY.O / OMIC.O / RPID.O / ABSI.O / SOPH.O</td><td class="leftalignment">Agilent Technologies Inc / Adaptive Biotechnologies Corp / Thermo Fisher Scientific Inc / Waters Corp / Quest Diagnostics Inc / Danaher Corp / ICON PLC / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / DENTSPLY SIRONA Inc / PerkinElmer Inc / Myriad Genetics Inc / Illumina Inc / Intuitive Surgical Inc / Charles River Laboratories International Inc / Hologic Inc / Quidel Corp / Bruker Corp / Qiagen NV / Pacific Biosciences of California Inc / Accelerate Diagnostics Inc / NanoString Technologies Inc / Catalent Inc / Invitae Corp / Natera Inc / Quanterix Corp / Syneos Health Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Envista Holdings Corp / 10X Genomics Inc / Renalytix PLC / Sotera Health Co / Seer Inc / Ortho Clinical Diagnostics Holdings PLC / Zymergen Inc / Singular Genomics Systems Inc / Rapid Micro Biosystems Inc / Absci Corp / Sophia Genetics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / China / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Chemicals / Healthcare / Industrial Materials / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CAPITALIZATION / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / SMALL CAPITAL / EVENT CALENDAR / MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tycho W. Peterson / Julia Qin / Ms. Rachel M. Vatnsdal / Mr. Casey Woodring</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2022 Outlook Webinar Replay: Here's What You Missed</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US03073E1055 / IE0005711209 / US1266501006 / US14149Y1082 / US1567821046 / US1598641074 / US58155Q1031 / US7677541044 / US8064071025 / US0162551016 / US7033951036 / US28238P1093 / US9314271084 / US87918A1051 / US24906P1093 / US46266C1053 / US87166B1026 / US29415F1049 / US68269G1076 / US8163073005 / US67181A1079 / GOCO US</td><td class="leftalignment">Amerisourcebergen Corp / ICON PLC / CVS Health Corp / Cardinal Health Inc / Cerner Corp / Charles River Laboratories International Inc / Mckesson Corp / Rite Aid Corp / Henry Schein Inc / Align Technology Inc / Patterson Companies Inc / eHealth Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / DENTSPLY SIRONA Inc / IQVIA Holdings Inc / Syneos Health Inc / Envista Holdings Corp / 1Life Healthcare Inc / SelectQuote Inc / Oak Street Health Inc / Gohealth Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2022 HC Tech & Distribution Outlook - Webinar at 10am ET - Rx Supply Chain, Heal</td><td class="leftalignment">English</td><td class="rightalignment">196</td><td class="leftalignment">US68269G1076 / IE0005711209 / US1266501006 / US14149Y1082 / US1567821046 / US1598641074 / US58155Q1031 / US7677541044 / US8064071025 / US0162551016 / US03073E1055 / US7033951036 / US28238P1093 / US9314271084 / US87918A1051 / US24906P1093 / US46266C1053 / US87166B1026 / US29415F1049 / US8163073005 / US67181A1079 / GOCO US / US8852601090</td><td class="leftalignment">1Life Healthcare Inc / ICON PLC / CVS Health Corp / Cardinal Health Inc / Cerner Corp / Charles River Laboratories International Inc / Mckesson Corp / Rite Aid Corp / Henry Schein Inc / Align Technology Inc / Amerisourcebergen Corp / Patterson Companies Inc / eHealth Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / DENTSPLY SIRONA Inc / IQVIA Holdings Inc / Syneos Health Inc / Envista Holdings Corp / SelectQuote Inc / Oak Street Health Inc / Gohealth Inc / Thorne Healthtech Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Charles River Laboratories International soars 375% in 5 years</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">01/01/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International slumps 9.6% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Will Charles River Laboratories International Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Three-bagger Carel Industries jumps 39% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Carel Industries S.P.A</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">IT0005331019</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">Italy</td><td class="leftalignment">Info. Tech./Software</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Comet Resources Limited</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">AU000000CRL0</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">Australia</td><td class="leftalignment">Miscellaneous</td><td class="leftalignment">Australasia</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Creightons plc</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">GB0002341666</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Household Products</td><td class="leftalignment">Europe</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Charles River Laboratories International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report</td><td class="leftalignment">English</td><td class="rightalignment">173</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Charles River Laboratories International, Inc.</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CRL-US Company reports financial results for the quarter ended September 25,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CRL / TMO / RGEN.O / SCYX.O</td><td class="leftalignment">Charles River Laboratories International Inc / Thermo Fisher Scientific Inc / Repligen Corp / SCYNEXIS Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/28/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Carel Industries climbs 9.7% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Creightons in bottom 8% performers of British market in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/24/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for CRL. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Is Comet Resources Ltd Still a Bargain?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Australasia</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Carl Data Solutions Inc</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">298</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Comet Resources in bottom 8% performers of Australian market in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Comet Resources Limited</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">A / ABT / AIT / BAX / BDX / BIO / CRL / DGX / DHR / GWW / LH / LLY.N / MSM / MTD / PKI / SON / TMO / WAT / WCC / MGM.N / ICLR.O / ILMN.O / TECH.O / FAST.O / HOLX.O / BLUE.O / EXAS.O / BRKR.O / MPLX.K / MEIP.O / FATE.O / NVTA.N / UNVR.K / NTRA.O / OLLI.O / GBT.O / IQV / QGEN.K / GH.O / AVTR.K / KREF.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Abbott Laboratories / Applied Industrial Technologies Inc / Baxter International Inc / Becton Dickinson and Co / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / W W Grainger Inc / Laboratory Corporation of America Holdings / Eli Lilly and Co / MSC Industrial Direct Co Inc / Mettler-Toledo International Inc / PerkinElmer Inc / Sonoco Products Co / Thermo Fisher Scientific Inc / Waters Corp / Wesco International Inc / MGM Resorts International / ICON PLC / Illumina Inc / Bio-Techne Corp / Fastenal Co / Hologic Inc / bluebird bio Inc / Exact Sciences Corp / Bruker Corp / MPLX LP / MEI Pharma Inc / Fate Therapeutics Inc / Invitae Corp / Univar Solutions Inc / Natera Inc / Ollie's Bargain Outlet Holdings Inc / Global Blood Therapeutics Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / KKR Real Estate Finance Trust Inc / Stevanato Group SpA</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Italy / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">The Pandemic Is Dead, Long Live the Endemic</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">DHR / HOLX.O / A / ABT / BDX / BIO / CRL / DGX / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K / STVN.N</td><td class="leftalignment">Danaher Corp / Hologic Inc / Agilent Technologies Inc / Abbott Laboratories / Becton Dickinson and Co / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / Stevanato Group SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Larry Biegelsen / Timothy Daley / Lu Li</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Health Serv & Equipment Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">US03763A2078 / US45783Q1004 / US0234361089 / US1598641074 / US4050241003 / US4612031017 / US74834L1008 / US46120E6023 / US2321091082 / US46121H1095 / US50187A1079 / US2521311074 / US1416191062 / US23335Q1004 / US05463X1063 / US44934S2068 / CA58457V5036 / US45780L1044 / US46266A1097 / US46071F1030 / US64157F1030 / US23283X2062 / US81255T1088 / US3773221029 / US87357P1003 / US81728J1097 / US58506Q1094 / US02081G2012 / US03767D1081 / US92214X1063 / US8753722037 / US87166B1026 / US64131A1051 / US09075F1075 / US8257041090 / US03837C1062 / US82489T1043 / US08862L1035 / US83192H1068 / US81362J2096 / US68404L2016 / US0051111096 / US2700871096 / US56600D1072 / US05356F1057</td><td class="leftalignment">Apollo Medical Holdings Inc / Inotiv Inc / Amedisys Inc / Charles River Laboratories International Inc / Haemonetics Corp / Invacare Corp / Quest Diagnostics Inc / Intuitive Surgical Inc / Cutera Inc / Intricon Corp / LHC Group Inc / Dexcom Inc / Cardiovascular Systems Inc / DLH Holdings Corp / AxoGen Inc / ICAD Inc / Medical Facilities Corp / Inogen Inc / IRadimed Corp / Intersect Ent Inc / Nevro Corp / Cytosorbents Corp / SeaSpine Holdings Corp / Glaukos Corp / Tactile Systems Technology Inc / Sensus Healthcare Inc / Medpace Holdings Inc / Alphatec Holdings Inc / Apollo Endosurgery Inc / Varex Imaging Corp / Tandem Diabetes Care Inc / Syneos Health Inc / Neuronetics Inc / Bionano Genomics Inc / SI-BONE Inc / Apyx Medical Corp / Shockwave Medical Inc / Beyond Air Inc / SmileDirectClub Inc / Second Sight Medical Products Inc / Option Care Health Inc / Acutus Medical Inc / Eargo Inc / Maravai LifeSciences Holdings Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LH: Management Catch Up Post Strategic Review Announcement</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LH.N / DGX.N / CRL.N / ICLR.OQ / MEDP.OQ / IQV.N / SYNH.OQ / CERT.OQ</td><td class="leftalignment">Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / ICON PLC / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Charles River Laboratories International Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Is Carl Data Solutions Inc Worth a Higher Bid?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Electronics / Info. Tech./Software / Technology</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Flow of Funds Report for Creightons PLC - prepared by Wright Investors Service</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Creightons PLC</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Health Serv & Equipment Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">US03763A2078 / US45783Q1004 / US0234361089 / US1598641074 / US4050241003 / US4612031017 / US74834L1008 / US46120E6023 / US2321091082 / US46121H1095 / US50187A1079 / US2521311074 / US1416191062 / US23335Q1004 / US05463X1063 / US44934S2068 / CA58457V5036 / US45780L1044 / US46266A1097 / US46071F1030 / US64157F1030 / US23283X2062 / US81255T1088 / US3773221029 / US87357P1003 / US81728J1097 / US58506Q1094 / US02081G2012 / US03767D1081 / US92214X1063 / US8753722037 / US87166B1026 / US64131A1051 / US09075F1075 / US8257041090 / US03837C1062 / US82489T1043 / US08862L1035 / US83192H1068 / US81362J2096 / US68404L2016 / US0051111096 / US2700871096 / US56600D1072 / US05356F1057</td><td class="leftalignment">Apollo Medical Holdings Inc / Inotiv Inc / Amedisys Inc / Charles River Laboratories International Inc / Haemonetics Corp / Invacare Corp / Quest Diagnostics Inc / Intuitive Surgical Inc / Cutera Inc / Intricon Corp / LHC Group Inc / Dexcom Inc / Cardiovascular Systems Inc / DLH Holdings Corp / AxoGen Inc / ICAD Inc / Medical Facilities Corp / Inogen Inc / IRadimed Corp / Intersect Ent Inc / Nevro Corp / Cytosorbents Corp / SeaSpine Holdings Corp / Glaukos Corp / Tactile Systems Technology Inc / Sensus Healthcare Inc / Medpace Holdings Inc / Alphatec Holdings Inc / Apollo Endosurgery Inc / Varex Imaging Corp / Tandem Diabetes Care Inc / Syneos Health Inc / Neuronetics Inc / Bionano Genomics Inc / SI-BONE Inc / Apyx Medical Corp / Shockwave Medical Inc / Beyond Air Inc / SmileDirectClub Inc / Second Sight Medical Products Inc / Option Care Health Inc / Acutus Medical Inc / Eargo Inc / Maravai LifeSciences Holdings Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Healthcare 2022 Outlook and Top Stock Recommendations</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">159864107 / 30161Q104 / 852312305 / 74838J101 / 45784P101 / 64049M20 / 268158201 / 450056106 / 720795103 / 01671P100 / 501147102 / 68404L201 / 00437E102 / 73730P108 / 15687V109 / 74276R102 / 57777K106</td><td class="leftalignment">Charles River Laboratories International Inc / Exelixis Inc / STAAR Surgical Co / Quidel Corp / Insulet Corp / Neogenomics Inc / Dynavax Technologies Corp / iRhythm Technologies Inc / Pieris Pharmaceuticals Inc / Allakos Inc / Krystal Biotech Inc / Option Care Health Inc / Accolade Inc / Poseida Therapeutics Inc / Certara Inc / Privia Health Group Inc / MaxCyte Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Mr. Raju Prasad, PHD / Brian D. Weinstein, CFA / Mr. Andrew F. Brackmann / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Healthcare Tech & Distribution – HealthCONx Conference Day 1 Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US1598641074 / IE0005711209 / US28176E1082 / US24906P1093 / US87166B1026</td><td class="leftalignment">Charles River Laboratories International Inc / ICON PLC / Edwards Lifesciences Corp / DENTSPLY SIRONA Inc / Syneos Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PZC-GB -  Dividend Quality Analysis, for the period ended November 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PZC.L / MCB.L / PFD.L / ULVR.L / CRGT.L</td><td class="leftalignment">PZ Cussons PLC / McBride PLC / Premier Foods PLC / Unilever PLC / Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Dec. 01, 2021 / 9:40AM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International sinks 18.4% from 4 week high</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Ownership Timelines & Shareholder Analytics (November 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CRL-GB -  Dividend Quality Analysis, for the period ended October 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CRGT.L / MCB.L / ULVR.L / PZC.L</td><td class="leftalignment">Creightons PLC / McBride PLC / Unilever PLC / PZ Cussons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, CRL</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Trending Topics - HealthCONx 4.0</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">US14149Y1082 / IE0005711209 / US1598641074 / US8064071025 / US28238P1093 / US9314271084 / US24906P1093 / US87166B1026 / US68269G1076 / US8163073005 / GOCO US / US8852601090</td><td class="leftalignment">Cardinal Health Inc / ICON PLC / Charles River Laboratories International Inc / Henry Schein Inc / eHealth Inc / Walgreens Boots Alliance Inc / DENTSPLY SIRONA Inc / Syneos Health Inc / 1Life Healthcare Inc / SelectQuote Inc / Gohealth Inc / Thorne Healthtech Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Elizabeth Anderson / Michael Newshel</td></tr>
<tr class="even"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Investor Targeting - November 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">A / AIG / AJG / ALL / AON / BBY / BIO / CB / COO / CRL / DGX / DHR / DOW / HIG / HUN / JNJ / KNX / LH / LNC / MA / MET / MMC / MTD / PGR / PKI / PRU / RE / RNR / TMO / TRV / V / WAT / WLK / BRO / CSCO.O / JBHT.O / NVDA.O / ICLR.O / HUBG.O / ILMN.O / TECH.O / AXS / LYB / HOLX.O / ACGL.O / EXAS.O / BRKR.O / XPO / SAIA.O / WRB.N / UIHC.O / VOYA.K / NVTA.N / NTRA.O / WLTW.O / BHF.O / IQV / QGEN.K / EQH / GH.O / AVTR.K / BRP.O / NWE.O / ROOT.O / STVN.N / RYAN.N / GXO.N / BBWI.N / VSCO.N</td><td class="leftalignment">Agilent Technologies Inc / American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / Aon PLC / Best Buy Co Inc / Bio Rad Laboratories Inc / Chubb Ltd / Cooper Companies Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Dow Inc / Hartford Financial Services Group Inc / Huntsman Corp / Johnson & Johnson / Knight-Swift Transportation Holdings Inc / Laboratory Corporation of America Holdings / Lincoln National Corp / Mastercard Inc / MetLife Inc / Marsh & McLennan Companies Inc / Mettler-Toledo International Inc / Progressive Corp / PerkinElmer Inc / Prudential Financial Inc / Everest Re Group Ltd / Renaissancere Holdings Ltd / Thermo Fisher Scientific Inc / Travelers Companies Inc / Visa Inc / Waters Corp / Westlake Chemical Corp / Brown & Brown Inc / Cisco Systems Inc / J B Hunt Transport Services Inc / NVIDIA Corp / ICON PLC / Hub Group Inc / Illumina Inc / Bio-Techne Corp / AXIS Capital Holdings Ltd / LyondellBasell Industries NV / Hologic Inc / Arch Capital Group Ltd / Exact Sciences Corp / Bruker Corp / XPO Logistics Inc / Saia Inc / W R Berkley Corp / United Insurance Holdings Corp / Voya Financial Inc / Invitae Corp / Natera Inc / Willis Towers Watson PLC / Brighthouse Financial Inc / IQVIA Holdings Inc / Qiagen NV / Equitable Holdings Inc / Guardant Health Inc / Avantor Inc / BRP Group Inc / NorthWestern Corp / Root Inc / Stevanato Group SpA / Ryan Specialty Group Holdings Inc / GXO Logistics Inc / Bath & Body Works Inc / Victoria's Secret & Co</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / China / Ireland / Italy / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Nov. 18, 2021 / 3:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">3Q21 Recap: Pick Your Battles, Recovery Likely Less Broad-Based from Here</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / Stevanato Group SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">HY Healthcare Check-Up : Wednesday, November 17 Roundup</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">DVA.N / CRL.N / SGRY.O</td><td class="leftalignment">DaVita Inc / Charles River Laboratories International Inc / Surgery Partners Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">David Common / Mr. Bradley H. Cobb</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Flow of Funds Report for Carel Industries SpA - prepared by Wright Investors Service</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment"></td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Carel Industries SpA</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment"></td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Housekeeping Monday: CRL and ICLR: Housekeeping Monday: Updating CRL and ICLR Models</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CRL.N / ICLR.OQ</td><td class="leftalignment">Charles River Laboratories International Inc / ICON PLC</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">George R. Hill</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Creightons PLC Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Agriculture / Beverages & Tobacco / Consumer / Cosmetics & Personal Care / Food / Household Products / Retailing / Services</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Peer Group Analytics - Q3 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/13/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Charles River Laboratories International: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CRL</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/13/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">CRL: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CRL</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Carel Industries jumps 36% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Creightons soars 52% in 2021, outperforming 84% of the market</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Carl Data Solutions Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Electronics / Info. Tech./Software / Technology</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Nov. 09, 2021 / 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare sector - Pfizer's Paxlovid expected to have limited impact on near-term vaccine demand; China small-molecule COVID drugs under active development</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRCG.DE / CRL.N / 2269.HK</td><td class="leftalignment">Pfizer Inc / Merck KGaA / Charles River Laboratories International Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Comet Resources climbs 10% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Information Content of Earnings Releases 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International sinks 15.6% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Post-Call Model Adjustments; Increasing Estimates for 2021 but Decreasing 2022 Given Investment Spend Commentary</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III / Justin Lin / Christine Rains</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Kiwoom Securities</td><td class="leftalignment">kiwoom 미 국 주 식 가 이드 weekly (2021.10.28~11.4)-11/04/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">28</td><td class="leftalignment">ANET / AOS / ATVI / BEN / CRL / F / NOC / GNRC / UAA</td><td class="leftalignment">Arista Networks Inc / A O Smith Corp / Activision Blizzard Inc / Franklin Resources Inc / Charles River Laboratories International Inc / Ford Motor Co / Northrop Grumman Corp / Generac Holdings Inc / Under Armour Inc</td><td class="leftalignment"></td><td class="leftalignment">Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment">RESEARCH SUMMARY / MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Won Ju Lee / Seong Jin Ji</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Notes from the Top - First Look at 2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Charles River Laboratories : 3Q21 Review: Noisy Quarter, Although 2021 and LT Targets Remain In-Tact; Maintain Overweight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">MARKET ANALYSIS / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tycho W. Peterson / Mr. Casey Woodring / Julia Qin / Ms. Rachel M. Vatnsdal</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AME / AWK / BAC / BSX / CRL / DD / EAT / EPD / H / HFC / PK / PNC / RKT / SWK / TFX / USB / WLK / HT / ATVI.O / BBBY.O / PAA.N / BJ.N / CHH.N / SHO.N / HST.N / XPO / CZR.O / RHP.N / VOYA.K / PFSI.K / USAC.K / PAGP.N / XHR.N / APLE.N / WING.O / PSTG.K / RRR.O / TRVG.O / SWCH.K / AUTL.O / RAMP.K / CPRI.K / LYFT.O / TRTX.K / HMPT.O / GXO.N</td><td class="leftalignment">AMETEK Inc / American Water Works Company Inc / Bank of America Corp / Boston Scientific Corp / Charles River Laboratories International Inc / Dupont De Nemours Inc / Brinker International Inc / Enterprise Products Partners LP / Hyatt Hotels Corp / HollyFrontier Corp / Park Hotels & Resorts Inc / PNC Financial Services Group Inc / Rocket Companies Inc / Stanley Black & Decker Inc / Teleflex Inc / US Bancorp / Westlake Chemical Corp / Hersha Hospitality Trust / Activision Blizzard Inc / Bed Bath & Beyond Inc / Plains All American Pipeline LP / BJ's Wholesale Club Holdings Inc / Choice Hotels International Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / Caesars Entertainment Inc / Ryman Hospitality Properties Inc / Voya Financial Inc / PennyMac Financial Services Inc / USA Compression Partners LP / Plains GP Holdings LP / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Wingstop Inc / Pure Storage Inc / Red Rock Resorts Inc / Trivago NV / Switch Inc / Autolus Therapeutics PLC / Liveramp Holdings Inc / Capri Holdings Ltd / Lyft Inc / TPG RE Finance Trust Inc / Home Point Capital Inc / GXO Logistics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">CRL: Q In line; Upsized Capex, Margin Pressures Weigh on Forecast</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CRL</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on November 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">TENR.MI / AEE.N / ALB.N / ALL.N / BP.L / CF.N / CVS.N / FLT.N / IBM.N / IR.N / SLB.N / PXD.N / HUM.N / ETR.N / HAL.N / MET.N / BWA.N / WTS.N / MGM.N / MRO.N / EMR.N / NI.N / XOM.N / LNC.N / H.N / AVA.N / IO.N / CRL.N / AAPL.OQ / MSFT.OQ / TRMB.OQ / SBUX.OQ / QCOM.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / 0700.HK / BDC.N / BLKB.OQ / RDSA.L / DISCA.OQ / 9999.HK / CLR.N / MNTX.OQ / BKR.N / EA.OQ / CDW.OQ / FOXA.OQ / PTC.OQ / NCLH.N / QRVO.OQ / ETSY.OQ / DXC.N / EQX.TO / WHD.N / CDAY.N / EVRG.N / IMXI.OQ / CTRA.N / LYFT.OQ / PINS.N / BYND.OQ / UBER.N / ZM.OQ / CTVA.N / TXG.OQ / EXC.OQ / 9988.HK / 9618.HK / LUMN.N / HST.OQ / ABNB.OQ</td><td class="leftalignment">Tenaris SA / Ameren Corp / Albemarle Corp / Allstate Corp / BP PLC / CF Industries Holdings Inc / CVS Health Corp / Fleetcor Technologies Inc / International Business Machines Corp / Ingersoll Rand Inc / Schlumberger NV / Pioneer Natural Resources Co / Humana Inc / Entergy Corp / Halliburton Co / MetLife Inc / Borgwarner Inc / Watts Water Technologies Inc / MGM Resorts International / Marathon Oil Corp / Emerson Electric Co / NiSource Inc / Exxon Mobil Corp / Lincoln National Corp / Hyatt Hotels Corp / Avista Corp / ION Geophysical Corp / Charles River Laboratories International Inc / Apple Inc / Microsoft Corp / Trimble Inc / Starbucks Corp / Qualcomm Inc / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Tencent Holdings Ltd / Belden Inc / Blackbaud Inc / Royal Dutch Shell PLC / Discovery Inc / NetEase Inc / Continental Resources Inc / Manitex International Inc / Baker Hughes Co / Electronic Arts Inc / CDW Corp / Fox Corp / PTC Inc / Norwegian Cruise Line Holdings Ltd / Qorvo Inc / ETSY Inc / DXC Technology Co / Equinox Gold Corp / Cactus Inc / Ceridian HCM Holding Inc / Evergy Inc / International Money Express Inc / Coterra Energy Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Corteva Inc / 10X Genomics Inc / Exelon Corp / Alibaba Group Holding Ltd / JD.Com Inc / Lumen Technologies Inc / Host Hotels & Resorts Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / Luxembourg / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">In-line Revs (13.6% core)/EPS Beat; Rev Guide Narrowed/EPS up</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Brief of Charles River Laboratories International Inc conference call, Nov. 03, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Nov. 03, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Good Earnings but Softer Top Line Provide First Hint of Cooling Demand</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III / Justin Lin / Christine Rains</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for CRL</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Charles River Laboratories International lifts 8.2% in past quarter; New York State Teachers Retirement System lifts 23.4%</td><td class="leftalignment">English</td><td class="rightalignment">77</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for CRL</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIOQ-US -  Dividend Quality Analysis, for the period ended October 20,2021.</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIOQ.PK / CRL / SGMO.O / CRIS.O / SGEN.O</td><td class="leftalignment">Bioqual Inc / Charles River Laboratories International Inc / Sangamo Therapeutics Inc / Curis Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Charles River Laboratories International (CRL: $448.68) continues significant uptrend; jumps 6%</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">A / AEP.N / AJG / AM / AMAT.O / AMT / AON / BAC / CCK / CCO / CNP / COF / CRL / DIS / DLR / DVN / EL / F.N / FNB / FND / FRC / GS / HIG / IDA / IPG / ITW / JCI / KIM / KLAC.O / LIN / MDC / MRO / NOC.N / NTB / OC / OMC / PNC / RE / RKT / RNR / SNV / SWK / SYK / SYY / TAP.N / TPR / UDR / WAL / AUD.N / CMCSA.O / WWE / ASB / AAPL.O / SBGI.O / MGM.N / SU.TO / JBT / HUBG.O / INTU.O / GTN / PBF / WERN.O / SIRI.O / CONE.O / SBUX.O / PACW.O / CHTR.O / HWM.N / EXPE.O / ARGX.O / CBSH.O / AXS / WBS / MU.O / FTV / HPE / TEAM.O / SIVB.O / UMBF.O / MMSI.O / BOKF.O / ACGL.O / UMPQ.O / EWBC.O / EQIX.O / PNFP.O / NFLX.O / CMCO.O / NXST.O / FHN / SBNY.O / TXRH.O / VIAC.O / RDSb / DISCA.O / STX.O / CNSL.O / ISBC.O / SAIA.O / CNK.N / FTNT.O / IMAX.N / NXPI.O / FIBK.O / CZR.O / BKU / AMCX.O / WDC.O / FANG.O / PFSI.K / FOXA.O / HMTV.O / MAR.O / GOOGL.O / BANC.K / TBK.O / QRVO.O / PBFX.K / TDOC.N / CABO.N / TGNA.K / WLTW.O / FHB.O / NGVT.K / LGFb.N / GOOS.TO / ATUS.N / BOMN.O / ROKU.O / IQV / VC.O / AVT.O / SPOT.K / SSP.O / KDP.N / OZK.O / REG.O / IHRT.O / AVTR.K / EXC.O / AVNT.K / CARR.K / HMPT.O / VZIO.N / BBWI.N</td><td class="leftalignment">Agilent Technologies Inc / American Electric Power Company Inc / Arthur J Gallagher & Co / Antero Midstream Corp / Applied Materials Inc / American Tower Corp / Aon PLC / Bank of America Corp / Crown Holdings Inc / Clear Channel Outdoor Holdings Inc / CenterPoint Energy Inc / Capital One Financial Corp / Charles River Laboratories International Inc / Walt Disney Co / Digital Realty Trust Inc / Devon Energy Corp / Estee Lauder Companies Inc / Ford Motor Co / FNB Corp / Floor & Decor Holdings Inc / First Republic Bank / Goldman Sachs Group Inc / Hartford Financial Services Group Inc / Idacorp Inc / Interpublic Group of Companies Inc / Illinois Tool Works Inc / Johnson Controls International PLC / Kimco Realty Corp / KLA Corp / Linde PLC / MDC Holdings Inc / Marathon Oil Corp / Northrop Grumman Corp / Bank of N T Butterfield & Son Ltd / Owens Corning / Omnicom Group Inc / PNC Financial Services Group Inc / Everest Re Group Ltd / Rocket Companies Inc / Renaissancere Holdings Ltd / Synovus Financial Corp / Stanley Black & Decker Inc / Stryker Corp / Sysco Corp / Molson Coors Beverage Co / Tapestry Inc / UDR Inc / Western Alliance Bancorp / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Associated Banc-Corp / Apple Inc / Sinclair Broadcast Group Inc / MGM Resorts International / Suncor Energy Inc / John Bean Technologies Corp / Hub Group Inc / Intuit Inc / Gray Television Inc / PBF Energy Inc / Werner Enterprises Inc / Sirius XM Holdings Inc / CyrusOne Inc / Starbucks Corp / PacWest Bancorp / Charter Communications Inc / Howmet Aerospace Inc / Expedia Group Inc / argenx SE / Commerce Bancshares Inc / AXIS Capital Holdings Ltd / Webster Financial Corp / Micron Technology Inc / Fortive Corp / Hewlett Packard Enterprise Co / Atlassian Corporation PLC / SVB Financial Group / UMB Financial Corp / Merit Medical Systems Inc / BOK Financial Corp / Arch Capital Group Ltd / Umpqua Holdings Corp / East West Bancorp Inc / Equinix Inc / Pinnacle Financial Partners Inc / Netflix Inc / Columbus McKinnon Corp / Nexstar Media Group Inc / First Horizon Corp / Signature Bank / Texas Roadhouse Inc / ViacomCBS Inc / Royal Dutch Shell PLC / Discovery Inc / Seagate Technology Holdings PLC / Consolidated Communications Holdings Inc / Investors Bancorp Inc / Saia Inc / Cinemark Holdings Inc / Fortinet Inc / Imax Corp / NXP Semiconductors NV / First Interstate BancSystem Inc / Caesars Entertainment Inc / BankUnited Inc / AMC Networks Inc / Western Digital Corp / Diamondback Energy Inc / PennyMac Financial Services Inc / Fox Corp / Hemisphere Media Group Inc / Marriott International Inc / Alphabet Inc / Banc of California Inc / Triumph Bancorp Inc / Qorvo Inc / PBF Logistics LP / Teladoc Health Inc / Cable One Inc / Tegna Inc / Willis Towers Watson PLC / First Hawaiian Inc / Ingevity Corp / Lions Gate Entertainment Corp / Canada Goose Holdings Inc / Altice USA Inc / Boston Omaha Corp / Roku Inc / IQVIA Holdings Inc / Visteon Corp / Avnet Inc / Spotify Technology SA / E W Scripps Co / Keurig Dr Pepper Inc / Bank Ozk / Regency Centers Corp / iHeartMedia Inc / Avantor Inc / Exelon Corp / Avient Corp / Carrier Global Corp / Home Point Capital Inc / Vizio Holding Corp / Bath & Body Works Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Eq Strat: When the Irrational Becomes Rational</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">A / AMAT.O / BAC / CNP / COF / CRL / DVN / EL / F.N / GS / HIG / JCI / KIM / MRO / PNC / SYY / TPR / UDR / MGM.N / INTU.O / HWM.N / EXPE.O / HPE / FTNT.O / CZR.O / FANG.O / MAR.O / GOOGL.O / IQV / REG.O / EXC.O / BBWI.N</td><td class="leftalignment">Agilent Technologies Inc / Applied Materials Inc / Bank of America Corp / CenterPoint Energy Inc / Capital One Financial Corp / Charles River Laboratories International Inc / Devon Energy Corp / Estee Lauder Companies Inc / Ford Motor Co / Goldman Sachs Group Inc / Hartford Financial Services Group Inc / Johnson Controls International PLC / Kimco Realty Corp / Marathon Oil Corp / PNC Financial Services Group Inc / Sysco Corp / Tapestry Inc / UDR Inc / MGM Resorts International / Intuit Inc / Howmet Aerospace Inc / Expedia Group Inc / Hewlett Packard Enterprise Co / Fortinet Inc / Caesars Entertainment Inc / Diamondback Energy Inc / Marriott International Inc / Alphabet Inc / IQVIA Holdings Inc / Regency Centers Corp / Exelon Corp / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Christopher P. Harvey / Gary S. Liebowitz, CFA / Anna Han</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Flow of Funds Report for Carl Data Solutions Inc - prepared by Wright Investors Service</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Comet Resources Ltd</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Australasia</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Flow of Funds Report for Comet Resources Limited - prepared by Wright Investors Service</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Charles River Laboratories International Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ULVR-GB -  Dividend Quality Analysis, for the period ended September 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ULVR.L / ABF.L / MCB.L / PFD.L / PZC.L / CRGT.L</td><td class="leftalignment">Unilever PLC / Associated British Foods PLC / McBride PLC / Premier Foods PLC / PZ Cussons PLC / Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">CRO Industry Update: Results From Fall 2021 Survey of Biopharmaceutical Sponsors</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">159864107 / G4705A100 / 58506Q109 / 46266C105 / 87166B102</td><td class="leftalignment">Charles River Laboratories International Inc / ICON PLC / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III / Christine Rains / Justin Lin</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">A / AMAT.O / AR / BIO / CCO / CLR / CNX / CPE / CRI / CRL / DG / DGX / DHR / DIS / DVN / EOG / EQT / GPS / HBI / IPG / KLAC.O / LH / LRCX.O / MGY / MRO / MTD / OMC / PKI / PVH / PXD / RL / RRC / SIG / SM / SWN / T / TJX / TMO / TPR / USB / VFC / WAT / WLL / WMT / ASML.O / AUD.N / CMCSA.O / WWE / SBGI.O / NVDA.O / ICLR.O / GTN / SIRI.O / NTAP.O / SMTC.O / ROST.O / CHTR.O / ILMN.O / TECH.O / AXS / LPI / MU.O / HPQ / URBN.O / HPE / TSCO.O / DKS.N / HOLX.O / MKSI.O / EXAS.O / NFLX.O / BRKR.O / NXST.O / DPZ / VIAC.O / DISCA.O / CNK.N / LULU.O / ULTA.O / NOG.A / IMAX.N / AMCX.O / ESTE.K / MTDR.K / PDCE.O / FANG.O / BCEI.K / FOXA.O / HMTV.O / BURL.K / NVTA.N / CABO.N / NTRA.O / TGNA.K / PSTG.K / LGFb.N / GOOS.TO / CDEV.O / ATUS.N / BOMN.O / ROKU.O / IQV / QGEN.K / SPOT.K / SSP.O / BRY.O / GH.O / CPRI.K / DELL.K / LEVI.N / IHRT.O / AVTR.K / OAS.O / OVV.N / CTRA.K / ASO.O / CHK.O / VZIO.N / TDUP.O / STVN.N / BBWI.N / VSCO.N</td><td class="leftalignment">Agilent Technologies Inc / Applied Materials Inc / Antero Resources Corp / Bio Rad Laboratories Inc / Clear Channel Outdoor Holdings Inc / Continental Resources Inc / CNX Resources Corp / Callon Petroleum Co / Carter's Inc / Charles River Laboratories International Inc / Dollar General Corp / Quest Diagnostics Inc / Danaher Corp / Walt Disney Co / Devon Energy Corp / EOG Resources Inc / EQT Corp / Gap Inc / HanesBrands Inc / Interpublic Group of Companies Inc / KLA Corp / Laboratory Corporation of America Holdings / Lam Research Corp / Magnolia Oil & Gas Corp / Marathon Oil Corp / Mettler-Toledo International Inc / Omnicom Group Inc / PerkinElmer Inc / PVH Corp / Pioneer Natural Resources Co / Ralph Lauren Corp / Range Resources Corp / Signet Jewelers Ltd / SM Energy Co / Southwestern Energy Co / AT&T Inc / TJX Companies Inc / Thermo Fisher Scientific Inc / Tapestry Inc / US Bancorp / VF Corp / Waters Corp / Whiting Petroleum Corp / Walmart Inc / ASML Holding NV / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Sinclair Broadcast Group Inc / NVIDIA Corp / ICON PLC / Gray Television Inc / Sirius XM Holdings Inc / NetApp Inc / Semtech Corp / Ross Stores Inc / Charter Communications Inc / Illumina Inc / Bio-Techne Corp / AXIS Capital Holdings Ltd / Laredo Petroleum Inc / Micron Technology Inc / HP Inc / Urban Outfitters Inc / Hewlett Packard Enterprise Co / Tractor Supply Co / DICK'S Sporting Goods Inc / Hologic Inc / MKS Instruments Inc / Exact Sciences Corp / Netflix Inc / Bruker Corp / Nexstar Media Group Inc / Domino's Pizza Inc / ViacomCBS Inc / Discovery Inc / Cinemark Holdings Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Northern Oil and Gas Inc / Imax Corp / AMC Networks Inc / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Civitas Resources Inc / Fox Corp / Hemisphere Media Group Inc / Burlington Stores Inc / Invitae Corp / Cable One Inc / Natera Inc / Tegna Inc / Pure Storage Inc / Lions Gate Entertainment Corp / Canada Goose Holdings Inc / Centennial Resource Development Inc / Altice USA Inc / Boston Omaha Corp / Roku Inc / IQVIA Holdings Inc / Qiagen NV / Spotify Technology SA / E W Scripps Co / Berry Corporation (Bry) / Guardant Health Inc / Capri Holdings Ltd / Dell Technologies Inc / Levi Strauss & Co / iHeartMedia Inc / Avantor Inc / Oasis Petroleum Inc / Ovintiv Inc / Coterra Energy Inc / Academy Sports and Outdoors Inc / Chesapeake Energy Corp / Vizio Holding Corp / ThredUp Inc / Stevanato Group SpA / Bath & Body Works Inc / Victoria's Secret & Co</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Italy / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Plenty Is Never Enough: Tools, EDx Tough; CROs Safer?</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / Stevanato Group SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Adjusting Estimates for Two Small Facility Divestitures</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III / Justin Lin / Christine Rains</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2021 Annual Report: Comet Resources reports EPS of -0.59c</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - 2021 Capital Markets Day - key takeaways</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">LONN.S / A.N / RECI.MI / TMO.N / AZN.L / DHR.N / LUN.CO / MRCG.DE / SATG.DE / CRL.N / UCB.BR / RGEN.OQ / SFZN.S / IPN.PA / ORNBV.HE / ALM.MC / MRNA.OQ / 068270.KS / CTLT.N / 207940.KS / 2269.HK / 091990.KQ / GMAB.CO / PPGN.S</td><td class="leftalignment">Lonza Group AG / Agilent Technologies Inc / Recordati Industria Chimica e Farmaceutica SpA / Thermo Fisher Scientific Inc / AstraZeneca PLC / Danaher Corp / H Lundbeck A/S / Merck KGaA / Sartorius AG / Charles River Laboratories International Inc / Ucb SA / Repligen Corp / Siegfried Holding AG / Ipsen SA / Orion Oyj / Almirall SA / Moderna Inc / Celltrion Inc / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / Genmab A/S / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Elizabeth Walton / Ms Jo Walton / Mr. Dominic Lunn / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Divests RMS Japan + Cognate Sweden Site for $140 MM; 10c dilutive to FY21</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">3Q Preview + Webinar: HC Tech & Distribution</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">US68269G1076 / IE0005711209 / US1266501006 / US14149Y1082 / US1567821046 / US1598641074 / US58155Q1031 / US7677541044 / US8064071025 / US0162551016 / US03073E1055 / US7033951036 / US28238P1093 / US9314271084 / US87918A1051 / US24906P1093 / US46266C1053 / US87166B1026 / US29415F1049 / US8163073005 / US67181A1079 / GOCO US</td><td class="leftalignment">1Life Healthcare Inc / ICON PLC / CVS Health Corp / Cardinal Health Inc / Cerner Corp / Charles River Laboratories International Inc / Mckesson Corp / Rite Aid Corp / Henry Schein Inc / Align Technology Inc / Amerisourcebergen Corp / Patterson Companies Inc / eHealth Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / DENTSPLY SIRONA Inc / IQVIA Holdings Inc / Syneos Health Inc / Envista Holdings Corp / SelectQuote Inc / Oak Street Health Inc / Gohealth Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Elizabeth Anderson / Michael Newshel</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Charles River Laboratories International soars 63% in 2021, beating 90% of the market</td><td class="leftalignment">English</td><td class="rightalignment">77</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Life Science Tools & Diagnostics  : 3Q21 Preview: Will Fundamentals Matter Heading into YE? Focus Remains on Macro Fears, Supply Chain Headwinds, Rising Int</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">A.N / ADPT.O / TMO.N / WAT.N / DGX.N / DHR.N / ICLR.O / LH.N / MTD.N / PKI.N / ILMN.O / ISRG.O / CRL.N / OSUR.O / HOLX.O / RGEN.O / QDEL.O / QGEN.N / NSTG.O / CTLT.N / NTRA.O / IQV.N / SYNH.O / GH.O / AVTR.N / TXG.O / BLI.O / OCDX.O / TLIS.O / ZY.O</td><td class="leftalignment">Agilent Technologies Inc / Adaptive Biotechnologies Corp / Thermo Fisher Scientific Inc / Waters Corp / Quest Diagnostics Inc / Danaher Corp / ICON PLC / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Illumina Inc / Intuitive Surgical Inc / Charles River Laboratories International Inc / OraSure Technologies Inc / Hologic Inc / Repligen Corp / Quidel Corp / Qiagen NV / NanoString Technologies Inc / Catalent Inc / Natera Inc / IQVIA Holdings Inc / Syneos Health Inc / Guardant Health Inc / Avantor Inc / 10X Genomics Inc / Berkeley Lights Inc / Ortho Clinical Diagnostics Holdings PLC / Talis Biomedical Corp / Zymergen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Chemicals / Conglomerates / Healthcare / Industrial Materials / Info. Tech./Computers / Manufacturing / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tycho W. Peterson</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Charles River Laboratories International Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: October 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIG.N / AIRP.PA / ALB.N / AN.N / AXP.N / BA.N / BAC.N / BMY.N / CB.N / CCI.N / CI.N / CL.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / JPM.N / KO.N / LLY.N / MMC.N / NEM.N / OXY.N / PFE.N / PHM.N / PPCJ.J / RHI.N / SC.N / T.N / TMO.N / WFC.N / WMT.N / ACI.N / AA.N / PG.N / HUM.N / NUE.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / DT.N / IPG.N / UNP.N / SPOT.N / GS.N / CLX.N / MCD.N / HD.N / LOW.N / MRO.N / UPS.N / MMM.N / XOM.N / DVN.N / NKE.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / PWR.N / V.N / ACN.N / WSM.N / JLL.N / HAE.N / SAM.N / CRL.N / CVX.N / COP.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / AGL.N / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / RGEN.OQ / SIVB.OQ / ZION.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / LNG.A / MRCY.OQ / NVDA.OQ / PACW.OQ / ISRG.OQ / ILMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / BIIB.OQ / TPX.N / TFC.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / CMG.N / FIS.N / STX.AX / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / PAG.N / TDC.N / TNDM.OQ / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / NLSN.N / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / ZNGA.OQ / EPAM.N / PSX.N / WDC.OQ / NOW.N / SRPT.OQ / PANW.N / FANG.OQ / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / OLLI.OQ / NVCR.OQ / PSTG.N / TMUS.OQ / IONS.OQ / TWLO.N / COUP.OQ / LW.N / ATUS.N / IOVA.OQ / ROKU.OQ / CBRE.N / FB.PS / STNE.OQ / CTRA.N / TER.OQ / NWL.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / LFG.AX / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">American International Group Inc / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / AutoNation Inc / American Express Co / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Marsh & McLennan Companies Inc / Newmont Corporation / Occidental Petroleum Corp / Pfizer Inc / Pultegroup Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Alcoa Corp / Procter & Gamble Co / Humana Inc / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / Dynatrace Inc / Interpublic Group of Companies Inc / Union Pacific Corp / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / 3M Co / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / Quanta Services Inc / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / agilon health Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Repligen Corp / SVB Financial Group / Zions Bancorporation NA / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / PacWest Bancorp / Intuitive Surgical Inc / Illumina Inc / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Biogen Inc / Tempur Sealy International Inc / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Penske Automotive Group Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Nielsen Holdings PLC / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Zynga Inc / Epam Systems Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Diamondback Energy Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Ollie's Bargain Outlet Holdings Inc / Novocure Ltd / Pure Storage Inc / T-Mobile US Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Altice USA Inc / Iovance Biotherapeutics Inc / Roku Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Coterra Energy Inc / Teradyne Inc / Newell Brands Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Liberty Financial Group Ltd / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/02/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">CHARLES RIVER LAB sees a downgrade to Slightly Negative on account of less fundamental stars</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Elevators & Escalators: Putting China developers risk into perspective. Reiterate constructive stance</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">KNEBV.HE / OTIS.N / 0123.HK / 0688.HK / 1109.HK / ASSAB.ST / GEBN.S / CRL.N / 600036.SS / 0081.HK / SCHP.S / 1233.HK / CG.TO / 3333.HK / 3383.HK / 600835.SS / LEGD.PA / 600048.SS / 0813.HK / 3900.HK / 3968.HK / 2007.HK / 1813.HK / 3377.HK / 1628.HK / 0960.HK / 1918.HK / 0884.HK / 3380.HK</td><td class="leftalignment">Kone Oyj / Otis Worldwide Corp / Yuexiu Property Co Ltd / China Overseas Land & Investment Ltd / China Resources Land Ltd / Assa Abloy AB / Geberit AG / Charles River Laboratories International Inc / China Merchants Bank Co Ltd / China Overseas Grand Oceans Group Ltd / Schindler Holding AG / Times China Holdings Ltd / Centerra Gold Inc / China Evergrande Group / Agile Group Holdings Ltd / Shanghai Mechanical & Electrical Industry Co Ltd / Legrand SA / Poly Developments and Holdings Group Co Ltd / Shimao Group Holdings Ltd / Greentown China Holdings Ltd / China Merchants Bank Co Ltd / Country Garden Holdings Co Ltd / KWG Group Holdings Ltd / Sino-Ocean Group Holding Ltd / Yuzhou Group Holdings Co Ltd / Longfor Group Holdings Ltd / Sunac China Holdings Ltd / CIFI Holdings (Group) Co Ltd / Logan Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / Finland / France / Hong Kong / Sweden / United States</td><td class="leftalignment">Manufacturing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Andre Kukhnin, CFA / Ms. Iris Zheng / Mr. John F. Walsh, Jr / Mr. Zhao Zhang / Mr Max R. Yates / Massimiliano Severi</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Charles River Laboratories International Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International jumps 12% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Charles River Laboratories International, Inc. SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Carel Industries SpA</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment"></td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools & Diagnostics : Termination of Coverage</td><td class="leftalignment">English</td><td class="rightalignment">59</td><td class="leftalignment">AVTR.N / CERT.OQ / TMO.N / DHR.N / CRL.N / IDXX.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / CNTG.OQ / MRVI.OQ / OCDX.OQ / SOPH.OQ</td><td class="leftalignment">Avantor Inc / Certara Inc / Thermo Fisher Scientific Inc / Danaher Corp / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Centogene NV / Maravai LifeSciences Holdings Inc / Ortho Clinical Diagnostics Holdings PLC / Sophia Genetics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">- Credit Suisse U Eq. Res.</td></tr>
<tr class="even"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">A / BIO / BSX / COF / CRL / DFS / DGX / DHR / JPM / KNX / LH / MTD / PKI / PNW / RKT / SLB.N / SPB / TMO / WAT / WLK / ASND.O / HAL.N / JBHT.O / ICLR.O / HUBG.O / LBRT.N / ILMN.O / TECH.O / HOLX.O / BLUE.O / EXAS.O / BRKR.O / NOV.N / XPO / SAIA.O / BKR.N / SLM.O / ARCT.O / GTLS.N / PFSI.K / NVTA.N / NTRA.O / ALLY.K / OMF / IQV / QGEN.K / GH.O / FLTRF.L / AVTR.K / EAR.O / HMPT.O / STVN.N / GXO.N</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Boston Scientific Corp / Capital One Financial Corp / Charles River Laboratories International Inc / Discover Financial Services / Quest Diagnostics Inc / Danaher Corp / JPMorgan Chase & Co / Knight-Swift Transportation Holdings Inc / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Pinnacle West Capital Corp / Rocket Companies Inc / Schlumberger NV / Spectrum Brands Holdings Inc / Thermo Fisher Scientific Inc / Waters Corp / Westlake Chemical Corp / Ascendis Pharma A/S / Halliburton Co / J B Hunt Transport Services Inc / ICON PLC / Hub Group Inc / Liberty Oilfield Services Inc / Illumina Inc / Bio-Techne Corp / Hologic Inc / bluebird bio Inc / Exact Sciences Corp / Bruker Corp / Nov Inc / XPO Logistics Inc / Saia Inc / Baker Hughes Co / SLM Corp / Arcturus Therapeutics Holdings Inc / Chart Industries Inc / PennyMac Financial Services Inc / Invitae Corp / Natera Inc / Ally Financial Inc / OneMain Holdings Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Flutter Entertainment PLC / Avantor Inc / Eargo Inc / Home Point Capital Inc / Stevanato Group SpA / GXO Logistics Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / Ireland / Italy / Netherlands / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">China Rising Tide but Not Lifting All Boats Equally</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / Stevanato Group SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Ireland / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Comet Resources in top 9% performers of Australian market in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">250</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ABT / ALC / AMT / AR / BA.N / BAC / BAX / BDX / BIO / BSX / CCI / CLR / CMG / CNI / CNX / COG / COO / CPE / CRL / CRM.N / DLR / DRI / DVN / DY / EAT / EL / EOG / EQT / FDX / GPS / HBI / IFF / JNJ / LNC / LXP / MCD / MDT / MGY / MRO / PEN / PGR / PXD / RKT / RNG / RRC / SIG / SM / STZ / SWN / SYK / T / TFX / UPS / USM / VFC / WAL / WLL / WRK / YUM / ASML.O / CMCSA.O / EW / IRM / AAPL.O / CBRL.O / ADBE.O / INTU.O / PAA.N / SBAC.O / GPK / CONE.O / IART.O / VZ / SBUX.O / CHTR.O / ISRG.O / LPI / CAKE.O / DKS.N / HOLX.O / TEAM.O / MMSI.O / EQIX.O / RRGB.O / MOH.N / DPZ / TXRH.O / PLAY.O / DENN.O / QSR / DXCM.O / BJRI.O / CNSL.O / CCOI.O / HALO.O / PODD.O / TNDM.OQ / NOG.A / CXM.N / JACK.O / LUNG.O / CZR.O / ESTE.K / WEN.O / GWRE.K / MTDR.K / PDCE.O / BLMN.O / FANG.O / BCEI.K / PFSI.K / RVNC.O / FLXN.O / FIVN.O / HUBS.K / ANTM.N / NVRO.K / QRVO.O / GKOS.K / WING.O / CABO.N / ZBH / NTRA.O / GBT.O / NVCR.O / TMUS.O / ADAP.O / EDIT.O / COUP.O / TWLO.K / UNIT.O / CDEV.O / ATUS.N / ZYME.K / WDAY.O / SWCH.K / EGHT.K / INSP.K / DOCU.O / SMAR.K / BRY.O / KZR.O / AXNX.O / CDAY.K / PLAN.K / SWAV.O / UBER.K / FLTRF.L / KRTX.O / OAS.O / OVV.N / DKNG.O / NARI.O / ZI.O / LUMN.K / ASO.O / BALY.N / EAR.O / DASH.N / RSI.N / CHK.O / HMPT.O / OSCR.N / PATH.N / NPCE.O / DBRG.N / BLND.N / DTM.N / YOU.N / WKME.O / CFLT.O / VSCO.N / KLTR.O / RXST.O</td><td class="leftalignment">Abbott Laboratories / Alcon AG / American Tower Corp / Antero Resources Corp / Boeing Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Bio Rad Laboratories Inc / Boston Scientific Corp / Crown Castle International Corp / Continental Resources Inc / Chipotle Mexican Grill Inc / Canadian National Railway Co / CNX Resources Corp / Coterra Energy Inc / Cooper Companies Inc / Callon Petroleum Co / Charles River Laboratories International Inc / Salesforce.Com Inc / Digital Realty Trust Inc / Darden Restaurants Inc / Devon Energy Corp / Dycom Industries Inc / Brinker International Inc / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / FedEx Corp / Gap Inc / HanesBrands Inc / International Flavors & Fragrances Inc / Johnson & Johnson / Lincoln National Corp / LXP Industrial Trust / McDonald's Corp / Medtronic PLC / Magnolia Oil & Gas Corp / Marathon Oil Corp / Penumbra Inc / Progressive Corp / Pioneer Natural Resources Co / Rocket Companies Inc / RingCentral Inc / Range Resources Corp / Signet Jewelers Ltd / SM Energy Co / Constellation Brands Inc / Southwestern Energy Co / Stryker Corp / AT&T Inc / Teleflex Inc / United Parcel Service Inc / United States Cellular Corp / VF Corp / Western Alliance Bancorp / Whiting Petroleum Corp / Westrock Co / Yum! Brands Inc / ASML Holding NV / Comcast Corp / Edwards Lifesciences Corp / Iron Mountain Inc / Apple Inc / Cracker Barrel Old Country Store Inc / Adobe Inc / Intuit Inc / Plains All American Pipeline LP / SBA Communications Corp / Graphic Packaging Holding Co / CyrusOne Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Starbucks Corp / Charter Communications Inc / Intuitive Surgical Inc / Laredo Petroleum Inc / Cheesecake Factory Inc / DICK'S Sporting Goods Inc / Hologic Inc / Atlassian Corporation PLC / Merit Medical Systems Inc / Equinix Inc / Red Robin Gourmet Burgers Inc / Molina Healthcare Inc / Domino's Pizza Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Restaurant Brands International Inc / Dexcom Inc / BJ's Restaurants Inc / Consolidated Communications Holdings Inc / Cogent Communications Holdings Inc / Halozyme Therapeutics Inc / Insulet Corp / Tandem Diabetes Care Inc / Northern Oil and Gas Inc / Sprinklr Inc / Jack in the Box Inc / Pulmonx Corp / Caesars Entertainment Inc / Earthstone Energy Inc / Wendys Co / Guidewire Software Inc / Matador Resources Co / PDC Energy Inc / Bloomin' Brands Inc / Diamondback Energy Inc / Civitas Resources Inc / PennyMac Financial Services Inc / Revance Therapeutics Inc / Pacira Biosciences Inc / Five9 Inc / HubSpot Inc / Anthem Inc / Nevro Corp / Qorvo Inc / Glaukos Corp / Wingstop Inc / Cable One Inc / Zimmer Biomet Holdings Inc / Natera Inc / Global Blood Therapeutics Inc / Novocure Ltd / T-Mobile US Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Coupa Software Inc / Twilio Inc / Uniti Group Inc / Centennial Resource Development Inc / Altice USA Inc / Zymeworks Inc / Workday Inc / Switch Inc / 8x8 Inc / Inspire Medical Systems Inc / DocuSign Inc / Smartsheet Inc / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Ceridian HCM Holding Inc / Anaplan Inc / Shockwave Medical Inc / Uber Technologies Inc / Flutter Entertainment PLC / Karuna Therapeutics Inc / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Inari Medical Inc / ZoomInfo Technologies Inc / Lumen Technologies Inc / Academy Sports and Outdoors Inc / Bally's Corp / Eargo Inc / DoorDash Inc / Rush Street Interactive Inc / Chesapeake Energy Corp / Home Point Capital Inc / Oscar Health Inc / UiPath Inc / Neuropace Inc / DigitalBridge Group Inc / Blend Labs Inc / DT Midstream Inc / Clear Secure Inc / Walkme Ltd / Confluent Inc / Victoria's Secret & Co / Kaltura Inc / Rxsight Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Carel Industries jumps 20% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Weekly Highlights—September 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ALC / BA.N / BAC / BIO / CNX / COG / CRL / DVN / EL / LXP / MDT / SIG / STZ / UPS / WLL / ASML.O / CMCSA.O / AAPL.O / PAA.N / CHTR.O / ISRG.O / HOLX.O / HALO.O / CZR.O / RVNC.O / FLXN.O / ANTM.N / QRVO.O / CABO.N / NTRA.O / GBT.O / ADAP.O / EDIT.O / CDEV.O / ATUS.N / ZYME.K / BRY.O / FLTRF.L / KRTX.O / OVV.N / DKNG.O / BALY.N / RSI.N / OSCR.N / DTM.N</td><td class="leftalignment">Alcon AG / Boeing Co / Bank of America Corp / Bio Rad Laboratories Inc / CNX Resources Corp / Coterra Energy Inc / Charles River Laboratories International Inc / Devon Energy Corp / Estee Lauder Companies Inc / LXP Industrial Trust / Medtronic PLC / Signet Jewelers Ltd / Constellation Brands Inc / United Parcel Service Inc / Whiting Petroleum Corp / ASML Holding NV / Comcast Corp / Apple Inc / Plains All American Pipeline LP / Charter Communications Inc / Intuitive Surgical Inc / Hologic Inc / Halozyme Therapeutics Inc / Caesars Entertainment Inc / Revance Therapeutics Inc / Pacira Biosciences Inc / Anthem Inc / Qorvo Inc / Cable One Inc / Natera Inc / Global Blood Therapeutics Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Centennial Resource Development Inc / Altice USA Inc / Zymeworks Inc / Berry Corporation (Bry) / Flutter Entertainment PLC / Karuna Therapeutics Inc / Ovintiv Inc / DraftKings Inc / Bally's Corp / Rush Street Interactive Inc / Oscar Health Inc / DT Midstream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for CRL. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Smart Insider</td><td class="leftalignment">Charles River Laboratories International Inc: 1 director</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / ECONOMIC INDICATORS / FUNDAMENTAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Company Snapshot</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Sep. 14, 2021 / 10:15AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALC / AZO / BIO / COO / CP / CRL / GPS / MDT / NSC / UPS / ASND.O / AAPL.O / ICLR.O / SGMO.O / ARNA.O / ISRG.O / HOLX.O / ORLY.O / DXCM.O / INFI.O / HALO.O / PODD.O / ARCT.O / QURE.O / ANTM.N / NTRA.O / GBT.O / IONS.O / ADAP.O / EDIT.O / JNCE.O / CLLS.O / ZYME.K / AUTL.O / BEAM.O / VRM.O / NARI.O / GRCL.O / OSCR.N / DTM.N</td><td class="leftalignment">Alcon AG / Autozone Inc / Bio Rad Laboratories Inc / Cooper Companies Inc / Canadian Pacific Railway Ltd / Charles River Laboratories International Inc / Gap Inc / Medtronic PLC / Norfolk Southern Corp / United Parcel Service Inc / Ascendis Pharma A/S / Apple Inc / ICON PLC / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / Intuitive Surgical Inc / Hologic Inc / O'Reilly Automotive Inc / Dexcom Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Insulet Corp / Arcturus Therapeutics Holdings Inc / Uniqure NV / Anthem Inc / Natera Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Autolus Therapeutics PLC / Beam Therapeutics Inc / Vroom Inc / Inari Medical Inc / Gracell Biotechnologies Inc / Oscar Health Inc / DT Midstream Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Sep. 13, 2021 / 10:15AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—September 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALC / AZO / BIO / COO / CRL / MDT / UPS / ASND.O / AAPL.O / ICLR.O / SGMO.O / ARNA.O / ISRG.O / HOLX.O / ORLY.O / DXCM.O / INFI.O / HALO.O / PODD.O / ARCT.O / QURE.O / ANTM.N / NTRA.O / GBT.O / IONS.O / ADAP.O / EDIT.O / JNCE.O / CLLS.O / ZYME.K / AUTL.O / BEAM.O / NARI.O / GRCL.O / OSCR.N / DTM.N</td><td class="leftalignment">Alcon AG / Autozone Inc / Bio Rad Laboratories Inc / Cooper Companies Inc / Charles River Laboratories International Inc / Medtronic PLC / United Parcel Service Inc / Ascendis Pharma A/S / Apple Inc / ICON PLC / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / Intuitive Surgical Inc / Hologic Inc / O'Reilly Automotive Inc / Dexcom Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Insulet Corp / Arcturus Therapeutics Holdings Inc / Uniqure NV / Anthem Inc / Natera Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Autolus Therapeutics PLC / Beam Therapeutics Inc / Inari Medical Inc / Gracell Biotechnologies Inc / Oscar Health Inc / DT Midstream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">A / ABT / ALB / ALC / AMT / ATR / AZO / BAX / BDX / BIO / BSX / CCI / COO / CRL / DFS / DGX / DHR / DLR / DY / INTC.O / JNJ / LH / LRCX.O / MDT / MTD / PEN / PKI / SYK / T / TFX / TMO / UPS / USM / WAT / ASND.O / ASML.O / EW / IRM / AAPL.O / CSCO.O / NVDA.O / ICLR.O / SBAC.O / CONE.O / SGMO.O / IART.O / AMD.O / VZ / NTAP.O / ARNA.O / ILMN.O / TECH.O / ISRG.O / HOLX.O / MMSI.O / EQIX.O / EXAS.O / BRKR.O / DXCM.O / CNSL.O / CCOI.O / INFI.O / CVLT.O / HALO.O / PODD.O / TNDM.OQ / LUNG.O / SLM.O / ARCT.O / WDC.O / QURE.O / ANET.K / ANTM.N / NVRO.K / NVTA.N / GKOS.K / ZBH / NTRA.O / GBT.O / PSTG.K / NVCR.O / TMUS.O / IONS.O / ADAP.O / EDIT.O / NTNX.O / JNCE.O / UNIT.O / CLLS.O / ZYME.K / SWCH.K / IQV / QGEN.K / INSP.K / AUTL.O / GH.O / AXNX.O / SWAV.O / AVTR.K / BEAM.O / NARI.O / LUMN.K / EAR.O / GRCL.O / OSCR.N / NPCE.O / DBRG.N / DTM.N / STVN.N / RXST.O</td><td class="leftalignment">Agilent Technologies Inc / Abbott Laboratories / Albemarle Corp / Alcon AG / American Tower Corp / Aptargroup Inc / Autozone Inc / Baxter International Inc / Becton Dickinson and Co / Bio Rad Laboratories Inc / Boston Scientific Corp / Crown Castle International Corp / Cooper Companies Inc / Charles River Laboratories International Inc / Discover Financial Services / Quest Diagnostics Inc / Danaher Corp / Digital Realty Trust Inc / Dycom Industries Inc / Intel Corp / Johnson & Johnson / Laboratory Corporation of America Holdings / Lam Research Corp / Medtronic PLC / Mettler-Toledo International Inc / Penumbra Inc / PerkinElmer Inc / Stryker Corp / AT&T Inc / Teleflex Inc / Thermo Fisher Scientific Inc / United Parcel Service Inc / United States Cellular Corp / Waters Corp / Ascendis Pharma A/S / ASML Holding NV / Edwards Lifesciences Corp / Iron Mountain Inc / Apple Inc / Cisco Systems Inc / NVIDIA Corp / ICON PLC / SBA Communications Corp / CyrusOne Inc / Sangamo Therapeutics Inc / Integra Lifesciences Holdings Corp / Advanced Micro Devices Inc / Verizon Communications Inc / NetApp Inc / Arena Pharmaceuticals Inc / Illumina Inc / Bio-Techne Corp / Intuitive Surgical Inc / Hologic Inc / Merit Medical Systems Inc / Equinix Inc / Exact Sciences Corp / Bruker Corp / Dexcom Inc / Consolidated Communications Holdings Inc / Cogent Communications Holdings Inc / Infinity Pharmaceuticals Inc / Commvault Systems Inc / Halozyme Therapeutics Inc / Insulet Corp / Tandem Diabetes Care Inc / Pulmonx Corp / SLM Corp / Arcturus Therapeutics Holdings Inc / Western Digital Corp / Uniqure NV / Arista Networks Inc / Anthem Inc / Nevro Corp / Invitae Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Natera Inc / Global Blood Therapeutics Inc / Pure Storage Inc / Novocure Ltd / T-Mobile US Inc / Ionis Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Nutanix Inc / Jounce Therapeutics Inc / Uniti Group Inc / Cellectis SA / Zymeworks Inc / Switch Inc / IQVIA Holdings Inc / Qiagen NV / Inspire Medical Systems Inc / Autolus Therapeutics PLC / Guardant Health Inc / Axonics Inc / Shockwave Medical Inc / Avantor Inc / Beam Therapeutics Inc / Inari Medical Inc / Lumen Technologies Inc / Eargo Inc / Gracell Biotechnologies Inc / Oscar Health Inc / Neuropace Inc / DigitalBridge Group Inc / DT Midstream Inc / Stevanato Group SpA / Rxsight Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Italy / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Higher for Life Sciences (2H August); Highlighting DHR and ZTS</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DHR.N / ZTS.N / A.N / BDX.N / TMO.N / WAT.N / PKI.N / CRL.N / IDXX.OQ / ILMN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / PAHC.OQ / PINFRAL.MX / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / CNTG.OQ / MRVI.OQ / CERT.OQ</td><td class="leftalignment">Danaher Corp / Zoetis Inc / Agilent Technologies Inc / Becton Dickinson and Co / Thermo Fisher Scientific Inc / Waters Corp / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Illumina Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Phibro Animal Health Corp / Promotora y Operadora de Infraestructura SAB de CV / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Mexico / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Katie A. Tryhane</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BANB.S: Bachem Holding - Once again: guidance increase</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BANB.S / A.N / TMO.N / LONN.S / CRL.N / SFZN.S / 068270.KS / CTLT.N / PINFRAL.MX / 207940.KS / 2269.HK / PPGN.S</td><td class="leftalignment">Bachem Holding AG / Agilent Technologies Inc / Thermo Fisher Scientific Inc / Lonza Group AG / Charles River Laboratories International Inc / Siegfried Holding AG / Celltrion Inc / Catalent Inc / Promotora y Operadora de Infraestructura SAB de CV / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Korea, Republic of / Mexico / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Fr. Barbora Blaha</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PPGN.S: PolyPeptide Group - Strong growth reflected in high valuation</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">PPGN.S / A.N / TMO.N / LONN.S / BANB.S / CRL.N / NVAX.OQ / 068270.KS / CTLT.N / PINFRAL.MX / 207940.KS / 2269.HK</td><td class="leftalignment">PolyPeptide Group AG / Agilent Technologies Inc / Thermo Fisher Scientific Inc / Lonza Group AG / Bachem Holding AG / Charles River Laboratories International Inc / Novavax Inc / Celltrion Inc / Catalent Inc / Promotora y Operadora de Infraestructura SAB de CV / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Korea, Republic of / Mexico / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Fr. Barbora Blaha / Herr. Christoph Gretler</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SFZN.S: Siegfried Holding - Heading into a strong H2</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">SFZN.S / A.N / TMO.N / LONN.S / BANB.S / CRL.N / NVAX.OQ / 068270.KS / CTLT.N / 207940.KS / 2269.HK</td><td class="leftalignment">Siegfried Holding AG / Agilent Technologies Inc / Thermo Fisher Scientific Inc / Lonza Group AG / Bachem Holding AG / Charles River Laboratories International Inc / Novavax Inc / Celltrion Inc / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Fr. Barbora Blaha</td></tr>
<tr class="even"><td class="leftalignment">09/12/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Quick Takes from Conference Firesides</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">A / AVTR.K / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Avantor Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Stevanato Group SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Croatia / Ireland / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">DHR: Investor Day Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">DHR.N / GE.N / TMO.N / CRL.N / CTLT.N / FTV.N / NVST.N</td><td class="leftalignment">Danaher Corp / General Electric Co / Thermo Fisher Scientific Inc / Charles River Laboratories International Inc / Catalent Inc / Fortive Corp / Envista Holdings Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Katie A. Tryhane</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Sep. 09, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Comet Resources Ltd Deliver Top-Shelf Performance?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Australasia</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Carl Data Solutions Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: September 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIRP.PA / ALB.N / AXP.N / BA.N / BAC.N / BAX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / IBM.N / JNJ.N / JPM.N / LLY.N / LMT.N / MDT.N / OXY.N / PFE.N / PM.N / PPCJ.J / RHI.N / SC.N / SLB.N / T.N / TMO.N / U.N / WAT.N / WFC.N / WMT.N / ACI.N / SPG.N / PG.N / HUM.N / NUE.N / CPB.N / HAL.N / DHR.N / UNH.N / IPG.N / SPOT.N / GS.N / CLX.N / VLO.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / KR.N / PCG.N / XOM.N / DVN.N / AMT.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / JCI.N / ORCL.N / VFC.N / V.N / ACN.N / WSM.N / PLD.N / JLL.N / HAE.N / SAM.N / BLK.N / CRL.N / CVX.N / IRM.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / REGN.OQ / RGEN.OQ / QDEL.OQ / SNPS.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / STLD.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / ERIE.OQ / NVDA.OQ / PLUG.OQ / MTCH.OQ / ISRG.OQ / BLUE.OQ / GRMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / SBNY.OQ / ACAD.OQ / EXR.N / MKTX.OQ / MPWR.OQ / LVS.N / NOV.N / DXCM.OQ / MS.N / CMG.N / FIS.N / STX.AX / HES.N / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / JAZZ.OQ / TDC.N / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / EPAM.N / PSX.N / NOW.N / SRPT.OQ / FANG.OQ / ABBV.N / BLDR.N / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / ARES.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / NVCR.OQ / PSTG.N / IONS.OQ / TWLO.N / COUP.OQ / LW.N / AYX.N / IOVA.OQ / ROKU.OQ / ZS.OQ / FB.PS / STNE.OQ / NFE.OQ / LYFT.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / MRVI.OQ / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Eli Lilly and Co / Lockheed Martin Corp / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Humana Inc / Nucor Corp / Campbell Soup Co / Halliburton Co / Danaher Corp / UnitedHealth Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / Kroger Co / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Johnson Controls International PLC / Oracle Corp / VF Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Prologis Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Iron Mountain Inc / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Repligen Corp / Quidel Corp / Synopsys Inc / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / Erie Indemnity Co / NVIDIA Corp / Plug Power Inc / Match Group Inc / Intuitive Surgical Inc / bluebird bio Inc / Garmin Ltd / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Extra Space Storage Inc / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Nov Inc / Dexcom Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Hess Corp / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Jazz Pharmaceuticals PLC / Teradata Corp / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Epam Systems Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / Builders FirstSource Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / Ares Management Corp / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Novocure Ltd / Pure Storage Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Roku Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / New Fortress Energy Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Maravai LifeSciences Holdings Inc / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Smart Insider</td><td class="leftalignment">Carel Industries S.p.A.: 1 director</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">IT0005331019</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment">Building & Building Materials</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / ECONOMIC INDICATORS / FUNDAMENTAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Company Snapshot</td></tr>
<tr class="odd"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Comet Resources Limited</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ICLR-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ICLR.O / CRL / SCYX.O / RDUS.O / CTLT.K</td><td class="leftalignment">ICON PLC / Charles River Laboratories International Inc / SCYNEXIS Inc / Radius Health Inc / Catalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Charles River Laboratories International (CRL: $443.86) climbs 9% in August, leads Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">A / ABT / BIO / BSX / CP / CRL / DGX / DHR / EL / GPS / HBI / KO / LH / MTD / NSC / PG / PKI / RKT / TMO / TPR / WAT / ICLR.O / ILMN.O / TECH.O / MNST.O / HOLX.O / EXAS.O / BRKR.O / PFSI.K / NVTA.N / NTRA.O / IQV / QGEN.K / KDP.N / GH.O / CPRI.K / AVTR.K / CHWY.K / HMPT.O / STVN.N / VSCO.N</td><td class="leftalignment">Agilent Technologies Inc / Abbott Laboratories / Bio Rad Laboratories Inc / Boston Scientific Corp / Canadian Pacific Railway Ltd / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Estee Lauder Companies Inc / Gap Inc / HanesBrands Inc / Coca-Cola Co / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / Norfolk Southern Corp / Procter & Gamble Co / PerkinElmer Inc / Rocket Companies Inc / Thermo Fisher Scientific Inc / Tapestry Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Monster Beverage Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / PennyMac Financial Services Inc / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Keurig Dr Pepper Inc / Guardant Health Inc / Capri Holdings Ltd / Avantor Inc / Chewy Inc / Home Point Capital Inc / Stevanato Group SpA / Victoria's Secret & Co</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Italy / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PCR Kit Shipments Continue to Rip; 3rd Week of August the 2nd Highest Week Ever</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / Stevanato Group SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Charles River Laboratories International Inc</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">A / ABT / ALC / AMAT.O / AR / ARW / BAC / BAX / BDX / BIO / BP.N / BSX / CLR / CNX / COG / COO / COP / CPE / CRL / CVX / DGX / DHR / DK / DVN / DY / EOG / EQT / GBX / GPS / HES / HFC / INTC.O / JNJ / KLAC.O / LH / LRCX.O / MCHP.O / MDT / MGY / MPC / MRO / MTD / MUR / NGL / OXY / PEN / PKI / PSX / PXD / QCOM.O / RMBS.O / RRC / SM / SUN / SWN / SYK / T / TFX / TMO / TRN / VLO / WAB / WAT / WLL / XLNX.O / CNQ.TO / ASML.O / ET / EW / AAPL.O / CSCO.O / NVDA.O / ICLR.O / SU.TO / XOM / PBF / SBAC.O / MXL / IART.O / AMD.O / ADI.O / VZ / NTAP.O / SMTC.O / SLAB.O / SNPS.O / DLTR.O / ILMN.O / TECH.O / ISRG.O / LPI / CREE.O / MU.O / MRVL.O / HPQ / HPE / AVGO.O / HOLX.O / DIOD.O / MMSI.O / MKSI.O / EXAS.O / SWKS.O / BRKR.O / NUVA.O / SHO.N / RDSb / DXCM.O / PSEC.O / CDNS.O / STX.O / SIMO.O / CLMT.O / CVLT.O / PODD.O / TNDM.OQ / ULTA.O / NOG.A / JNPR.K / TSLA.O / NXPI.O / LUNG.O / ESTE.K / MTDR.K / WDC.O / TRGP.K / PDCE.O / GMED.K / AMBA.O / FANG.O / MPLX.K / BCEI.K / ANET.K / ENLC.K / NVRO.K / QRVO.O / NVTA.N / ON.O / GKOS.K / ZBH / NTRA.O / SPNE.O / OLLI.O / PSTG.K / NVCR.O / TMUS.O / GATX.K / NTNX.O / CDEV.O / IQV / QGEN.K / AVT.O / INSP.K / BRY.O / GH.O / AXNX.O / DELL.K / SWAV.O / AVTR.K / FTCH.K / ETRN.K / OAS.O / OVV.N / NARI.O / OM.O / EAR.O / ALGM.O / GRCL.O / CHK.O / NPCE.O / STVN.N / RXST.O</td><td class="leftalignment">Agilent Technologies Inc / Abbott Laboratories / Alcon AG / Applied Materials Inc / Antero Resources Corp / Arrow Electronics Inc / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Bio Rad Laboratories Inc / BP PLC / Boston Scientific Corp / Continental Resources Inc / CNX Resources Corp / Coterra Energy Inc / Cooper Companies Inc / Conocophillips / Callon Petroleum Co / Charles River Laboratories International Inc / Chevron Corp / Quest Diagnostics Inc / Danaher Corp / Delek US Holdings Inc / Devon Energy Corp / Dycom Industries Inc / EOG Resources Inc / EQT Corp / Greenbrier Companies Inc / Gap Inc / Hess Corp / HollyFrontier Corp / Intel Corp / Johnson & Johnson / KLA Corp / Laboratory Corporation of America Holdings / Lam Research Corp / Microchip Technology Inc / Medtronic PLC / Magnolia Oil & Gas Corp / Marathon Petroleum Corp / Marathon Oil Corp / Mettler-Toledo International Inc / Murphy Oil Corp / NGL Energy Partners LP / Occidental Petroleum Corp / Penumbra Inc / PerkinElmer Inc / Phillips 66 / Pioneer Natural Resources Co / Qualcomm Inc / Rambus Inc / Range Resources Corp / SM Energy Co / Sunoco LP / Southwestern Energy Co / Stryker Corp / AT&T Inc / Teleflex Inc / Thermo Fisher Scientific Inc / Trinity Industries Inc / Valero Energy Corp / Westinghouse Air Brake Technologies Corp / Waters Corp / Whiting Petroleum Corp / Xilinx Inc / Canadian Natural Resources Ltd / ASML Holding NV / Energy Transfer LP / Edwards Lifesciences Corp / Apple Inc / Cisco Systems Inc / NVIDIA Corp / ICON PLC / Suncor Energy Inc / Exxon Mobil Corp / PBF Energy Inc / SBA Communications Corp / Maxlinear Inc / Integra Lifesciences Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Verizon Communications Inc / NetApp Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Dollar Tree Inc / Illumina Inc / Bio-Techne Corp / Intuitive Surgical Inc / Laredo Petroleum Inc / Wolfspeed Inc / Micron Technology Inc / Marvell Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Hologic Inc / Diodes Inc / Merit Medical Systems Inc / MKS Instruments Inc / Exact Sciences Corp / Skyworks Solutions Inc / Bruker Corp / NuVasive Inc / Sunstone Hotel Investors Inc / Royal Dutch Shell PLC / Dexcom Inc / Prospect Capital Corp / Cadence Design Systems Inc / Seagate Technology Holdings PLC / Silicon Motion Technology Corp / Calumet Specialty Products Partners LP / Commvault Systems Inc / Insulet Corp / Tandem Diabetes Care Inc / Ulta Beauty Inc / Northern Oil and Gas Inc / Juniper Networks Inc / Tesla Inc / NXP Semiconductors NV / Pulmonx Corp / Earthstone Energy Inc / Matador Resources Co / Western Digital Corp / Targa Resources Corp / PDC Energy Inc / Globus Medical Inc / Ambarella Inc / Diamondback Energy Inc / MPLX LP / Civitas Resources Inc / Arista Networks Inc / EnLink Midstream LLC / Nevro Corp / Qorvo Inc / Invitae Corp / ON Semiconductor Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Natera Inc / SeaSpine Holdings Corp / Ollie's Bargain Outlet Holdings Inc / Pure Storage Inc / Novocure Ltd / T-Mobile US Inc / GATX Corp / Nutanix Inc / Centennial Resource Development Inc / IQVIA Holdings Inc / Qiagen NV / Avnet Inc / Inspire Medical Systems Inc / Berry Corporation (Bry) / Guardant Health Inc / Axonics Inc / Dell Technologies Inc / Shockwave Medical Inc / Avantor Inc / Farfetch Ltd / Equitrans Midstream Corp / Oasis Petroleum Inc / Ovintiv Inc / Inari Medical Inc / Outset Medical Inc / Eargo Inc / Allegro Microsystems Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Neuropace Inc / Stevanato Group SpA / Rxsight Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Italy / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Comet Resources gains 11% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">COVID TAM Update: mAbs >$1.5B in a Post-Vax World</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / Stevanato Group SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Ownership Timelines & Shareholder Analytics (August 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Creightons PLC</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Healthcare Insights:Scanning the Healthcare Landscape for Quality Growth Ideas</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CNC.N / RMD.N / CRL.N</td><td class="leftalignment">Centene Corp / Resmed Inc / Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steven Bock / Angelo Policicchio / HOLT Americas</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">A / AAP / ABT / ALC / AWK / AWR / AZO / BAX / BBY / BDX / BIO / BSX / CRL / CWT / DGX / DHR / EIX / JNJ / LH / MDT / MTD / PCG / PKI / SJW / SRE / SYK / TFX / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / ORLY.O / EXAS.O / BRKR.O / SHO.N / HST.N / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / CPRI.K / AVTR.K / STVN.N / RXST.O</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Abbott Laboratories / Alcon AG / American Water Works Company Inc / American States Water Co / Autozone Inc / Baxter International Inc / Best Buy Co Inc / Becton Dickinson and Co / Bio Rad Laboratories Inc / Boston Scientific Corp / Charles River Laboratories International Inc / California Water Service Group / Quest Diagnostics Inc / Danaher Corp / Edison International / Johnson & Johnson / Laboratory Corporation of America Holdings / Medtronic PLC / Mettler-Toledo International Inc / PG&E Corp / PerkinElmer Inc / SJW Group / Sempra Energy / Stryker Corp / Teleflex Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / O'Reilly Automotive Inc / Exact Sciences Corp / Bruker Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Capri Holdings Ltd / Avantor Inc / Stevanato Group SpA / Rxsight Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / Italy / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Weekly PCR Shipments Moderate to More-Normal Levels, but Strengthen Case for 3Q21 Upside</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / Stevanato Group SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics : Short Interest Higher for Life Sciences (1H August); Highlighting IDXX and IQV</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">IDXX.OQ / IQV.N / A.N / BDX.N / TMO.N / WAT.N / DHR.N / PKI.N / CRL.N / ILMN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / MEDP.OQ / FLGT.O / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">IDEXX Laboratories Inc / IQVIA Holdings Inc / Agilent Technologies Inc / Becton Dickinson and Co / Thermo Fisher Scientific Inc / Waters Corp / Danaher Corp / PerkinElmer Inc / Charles River Laboratories International Inc / Illumina Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Medpace Holdings Inc / Fulgent Genetics Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Katie A. Tryhane</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, CRL</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Is Carl Data Solutions Inc Still a Bargain?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Electronics / Info. Tech./Software / Technology</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Carel Industries jumps 18% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">A / AIG / AJG / ALL / ALV / ALV.N / AMAT.O / AON / BIO / BWA / CB / CRL / DFS / DGX / DHR / ED / EIX / EL / F.N / GM.N / HIG / LH / LNC / MET / MGA / MMC / MTD / PGR / PKI / PRU / RE / RMBS.O / RNR / TMO / TRV / WAT / TEN.N / BRO / BWA.N / LEA.N / ICLR.O / MGA.N / ROST.O / ILMN.O / AXS / HOLX.O / ACGL.O / EXAS.O / BRKR.O / DRH.N / DAN.N / WRB.N / TSLA.O / SLM.O / UIHC.O / VOYA.K / NVTA.N / NTRA.O / WLTW.O / ADNT.N / BHF.O / IQV / APTV.N / VC.O / QGEN.K / EQH / GH.O / AVTR.K / FTCH.K / CRNC.O / BRP.O / ROOT.O / BLND.N / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / Autoliv Inc / Autoliv Inc / Applied Materials Inc / Aon PLC / Bio Rad Laboratories Inc / Borgwarner Inc / Chubb Ltd / Charles River Laboratories International Inc / Discover Financial Services / Quest Diagnostics Inc / Danaher Corp / Consolidated Edison Inc / Edison International / Estee Lauder Companies Inc / Ford Motor Co / General Motors Co / Hartford Financial Services Group Inc / Laboratory Corporation of America Holdings / Lincoln National Corp / MetLife Inc / Magna International Inc / Marsh & McLennan Companies Inc / Mettler-Toledo International Inc / Progressive Corp / PerkinElmer Inc / Prudential Financial Inc / Everest Re Group Ltd / Rambus Inc / Renaissancere Holdings Ltd / Thermo Fisher Scientific Inc / Travelers Companies Inc / Waters Corp / Tenneco Inc / Brown & Brown Inc / Borgwarner Inc / Lear Corp / ICON PLC / Magna International Inc / Ross Stores Inc / Illumina Inc / AXIS Capital Holdings Ltd / Hologic Inc / Arch Capital Group Ltd / Exact Sciences Corp / Bruker Corp / Diamondrock Hospitality Co / Dana Inc / W R Berkley Corp / Tesla Inc / SLM Corp / United Insurance Holdings Corp / Voya Financial Inc / Invitae Corp / Natera Inc / Willis Towers Watson PLC / Adient PLC / Brighthouse Financial Inc / IQVIA Holdings Inc / Aptiv PLC / Visteon Corp / Qiagen NV / Equitable Holdings Inc / Guardant Health Inc / Avantor Inc / Farfetch Ltd / Cerence Inc / BRP Group Inc / Root Inc / Blend Labs Inc / Stevanato Group SpA</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Italy / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">De-Risking the Theme; OK to Own Tools/Dx Again</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / Stevanato Group SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Life Science Tools & Dx : 2Q21 Review: Latest Thoughts on the Group, Base Recovery, Delta Risks, and What to Own Right Now</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">A.N / DGX.N / ICLR.O / LH.N / MTD.N / PKI.N / MYGN.O / ILMN.O / CRL.N / OSUR.O / HOLX.O / RGEN.O / QDEL.O / QGEN.N / AXDX.O / NSTG.O / TXG.O / BLI.O / OCDX.O</td><td class="leftalignment">Agilent Technologies Inc / Quest Diagnostics Inc / ICON PLC / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Myriad Genetics Inc / Illumina Inc / Charles River Laboratories International Inc / OraSure Technologies Inc / Hologic Inc / Repligen Corp / Quidel Corp / Qiagen NV / Accelerate Diagnostics Inc / NanoString Technologies Inc / 10X Genomics Inc / Berkeley Lights Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / INITIAL PUBLIC OFFERINGS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / SMALL CAPITAL / MORNING COMMENTS / PORTFOLIO STRATEGY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tycho W. Peterson / Julia Qin / Mr. Casey Woodring</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">A / AEE / AIG / BIO / CMS / CRL / DGX / DHR / ETR / LH / MTD / PKI / TMO / WAT / WEC / ICLR.O / ILMN.O / TECH.O / FTS.TO / HOLX.O / ACGL.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / EOLS.O / GH.O / OSMT.O / LNT.O / AVTR.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Ameren Corp / American International Group Inc / Bio Rad Laboratories Inc / CMS Energy Corp / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Entergy Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / WEC Energy Group Inc / ICON PLC / Illumina Inc / Bio-Techne Corp / Fortis Inc / Hologic Inc / Arch Capital Group Ltd / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Evolus Inc / Guardant Health Inc / Osmotica Pharmaceuticals PLC / Alliant Energy Corp / Avantor Inc / Stevanato Group SpA</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Italy / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Creightons PLC Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Agriculture / Beverages & Tobacco / Consumer / Cosmetics & Personal Care / Food / Household Products / Retailing / Services</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PCR Testing Still Dragging below Peak, but Vendor Shipments Just Spiked Vertical to Winter ’20/21 Levels</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K / STVN.N</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / Stevanato Group SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / INTERNAL REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Contract Research Organizations: CRO Download - 2Q Reports Underscore Our Positive Bias on the CRO Landscape; Robust Biotech Funding</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">TMO.N / DGX.N / LH.N / LONN.S / WST.N / CRL.N / ICLR.OQ / CTLT.N / MEDP.OQ / IQV.N / SYNH.OQ / CERT.OQ</td><td class="leftalignment">Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Katie A. Tryhane</td></tr>
<tr class="odd"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Lower for Life Sciences (2H July); Highlighting ZTS and TMO</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">TMO.N / ZTS.N / A.N / WAT.N / DHR.N / PKI.N / CRL.N / IDXX.OQ / ILMN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / PAHC.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Thermo Fisher Scientific Inc / Zoetis Inc / Agilent Technologies Inc / Waters Corp / Danaher Corp / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Illumina Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Phibro Animal Health Corp / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Katie A. Tryhane</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FISV=US / PFE=US / ICLR=US / MDT=US / AMZN=US / T=US / EBAY=US / RUN=US / APA=US / PLUG=US / CRM=US / VRM=US / EXPE=US / TNL=US / MDRX=US / MGM=US / W=US / DV=US / AMED=US / AMN=US / PATH=US / ATRO=US / ENV=US / CENT=US / CERN=US / CRL=US / COLL=US / DVA=US / EPC=US / EXAS=US / GPOR=US / MEDP=US / SGMO=US / SMG=US / SNAP=US / TRGP=US / TRIP=US / WIX=US / POST=US / GPN=US / CCRN=US / BKNG=US / AVTR=US / PRI=US / FB=US / MTCH=US / NTRA=US / VICI=US / MGP=US / MGPI=US / BDSI=US / MD=US / MNST=US / PTON=US / NOMD=US / APP=US / BECN=US / AWH / FRPT=US / THS=US / BLDR=US / CHNG=US / FIS=US / CENTA=US / LUMN=US / NXGN=US / ATSG=US / NEO=US / 45665G303 / HGV=US / ESTE=US / VAC=US / ANGI=US / TILE=US / NCLH=US / VEEV=US / VCYT=US / GOOGL=US / QTWO=US / FIVN=US / 00770K202 / HQY=US / BABA=US / CMPR=US / GDDY=US / EVH=US / TDOC=US / WVE=US / EDIT=US / TRHC=US / LGF.B=US / CVNA=US / IOVA=US / RDFN=US / PETQ=US / IQV=US / SFIX=US / SYNH=US / EQH=US / FTDR=US / EB=US / ARVN=US / LYFT=US / UBER=US / NXTC=US / PSNL=US / RPAY=US / HCAT=US / BRBR=US / REYN=US / SPCE=US / DKNG=US / PAYA=US / DHT.UN=CA / VMEO=US / MNTV=US / CNVY</td><td class="leftalignment">Fiserv Inc / Pfizer Inc / ICON PLC / Medtronic PLC / Amazon.com Inc / AT&T Inc / eBay Inc / Sunrun Inc / APA Corp (US) / Plug Power Inc / Salesforce.Com Inc / Vroom Inc / Expedia Group Inc / Travel + Leisure Co / Allscripts Healthcare Solutions Inc / MGM Resorts International / Wayfair Inc / DoubleVerify Holdings Inc / Amedisys Inc / AMN Healthcare Services Inc / UiPath Inc / Astronics Corp / Envestnet Inc / Central Garden & Pet Co / Cerner Corp / Charles River Laboratories International Inc / Collegium Pharmaceutical Inc / DaVita Inc / Edgewell Personal Care Co / Exact Sciences Corp / Gulfport Energy Corp / Medpace Holdings Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Snap Inc / Targa Resources Corp / Tripadvisor Inc / Wix.Com Ltd / Post Holdings Inc / Global Payments Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Avantor Inc / Primerica Inc / Meta Platforms Inc / Match Group Inc / Natera Inc / VICI Properties Inc / MGM Growth Properties LLC / MGP Ingredients Inc / BioDelivery Sciences International Inc / MEDNAX Inc / Monster Beverage Corp / Peloton Interactive Inc / Nomad Foods Ltd / Applovin Corp / Beacon Roofing Supply Inc / Aspira Women's Health Inc / Freshpet Inc / TreeHouse Foods Inc / Builders FirstSource Inc / Change Healthcare Inc / Fidelity National Information Services Inc / Central Garden & Pet Co / Lumen Technologies Inc / NextGen Healthcare Inc / Air Transport Services Group Inc / Neogenomics Inc / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Interface Inc / Norwegian Cruise Line Holdings Ltd / Veeva Systems Inc / Veracyte Inc / Alphabet Inc / Q2 Holdings Inc / Five9 Inc / Aemetis Inc / Healthequity Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Evolent Health Inc / Teladoc Health Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Tabula Rasa HealthCare Inc / Lions Gate Entertainment Corp / Carvana Co / Iovance Biotherapeutics Inc / Redfin Corp / PetIQ Inc / IQVIA Holdings Inc / Stitch Fix Inc / Syneos Health Inc / Equitable Holdings Inc / Frontdoor Inc / Eventbrite Inc / Arvinas Inc / Lyft Inc / Uber Technologies Inc / NextCure Inc / Personalis Inc / Repay Holdings Corp / Health Catalyst Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / DraftKings Inc / Paya Holdings Inc / Dri Healthcare Trust / Vimeo Inc / Momentive Global Inc / Convey Health Solutions Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Ireland / Israel / Singapore / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">A / ABT / AIG / ALC / ALL / AMT / BAX / BDX / BIO / BIP / BLL / BSX / CB / CCI / CCO / CMG / COO / CRL / DCP / DFS / DGX / DHR / DIS / DLR / DRI / DY / HIG / IFF / IPG / JNJ / LH / LNC / MCD / MDT / MET / MGA / MTD / OMC / PEN / PGR / PKI / SPB / SYK / T / TFX / TMO / USM / WAT / YUM / AUD.N / CMCSA.O / EW / WWE / IRM / LEA.N / SBGI.O / ICLR.O / MGA.N / SBAC.O / SIRI.O / CONE.O / IART.O / VZ / SBUX.O / CHTR.O / ILMN.O / TECH.O / ISRG.O / CAKE.O / PLUG.OQ / HOLX.O / MMSI.O / ACGL.O / EQIX.O / EXAS.O / NFLX.O / BRKR.O / NXST.O / AINV.O / NUVA.O / VIAC.O / QSR / DXCM.O / DISCA.O / BJRI.O / CNSL.O / CLMT.O / CCOI.O / TDG.N / PODD.O / BKCC.O / TNDM.OQ / WRB.N / TRIN.O / JACK.O / LUNG.O / GEI.TO / AMCX.O / ANGI.O / SLM.O / TCPC.O / GMED.K / UIHC.O / FOXA.O / HMTV.O / NVRO.K / NVTA.N / GKOS.K / CABO.N / ZBH / NTRA.O / TGNA.K / SPNE.O / NVCR.O / TMUS.O / LGFb.N / GSBD.K / UNIT.O / ATUS.N / BHF.O / BOMN.O / ROKU.O / SWCH.K / IQV / QGEN.K / INSP.K / SPOT.K / SSP.O / BBDC.K / GH.O / AXNX.O / SWAV.O / IHRT.O / AVTR.K / BIPC.K / NARI.O / OM.O / LUMN.K / EAR.O / VZIO.N / NPCE.O / DBRG.N / PECO.O</td><td class="leftalignment">Agilent Technologies Inc / Abbott Laboratories / American International Group Inc / Alcon AG / Allstate Corp / American Tower Corp / Baxter International Inc / Becton Dickinson and Co / Bio Rad Laboratories Inc / Brookfield Infrastructure Partners LP / Ball Corp / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Clear Channel Outdoor Holdings Inc / Chipotle Mexican Grill Inc / Cooper Companies Inc / Charles River Laboratories International Inc / DCP Midstream LP / Discover Financial Services / Quest Diagnostics Inc / Danaher Corp / Walt Disney Co / Digital Realty Trust Inc / Darden Restaurants Inc / Dycom Industries Inc / Hartford Financial Services Group Inc / International Flavors & Fragrances Inc / Interpublic Group of Companies Inc / Johnson & Johnson / Laboratory Corporation of America Holdings / Lincoln National Corp / McDonald's Corp / Medtronic PLC / MetLife Inc / Magna International Inc / Mettler-Toledo International Inc / Omnicom Group Inc / Penumbra Inc / Progressive Corp / PerkinElmer Inc / Spectrum Brands Holdings Inc / Stryker Corp / AT&T Inc / Teleflex Inc / Thermo Fisher Scientific Inc / United States Cellular Corp / Waters Corp / Yum! Brands Inc / Audacy Inc / Comcast Corp / Edwards Lifesciences Corp / World Wrestling Entertainment Inc / Iron Mountain Inc / Lear Corp / Sinclair Broadcast Group Inc / ICON PLC / Magna International Inc / SBA Communications Corp / Sirius XM Holdings Inc / CyrusOne Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Starbucks Corp / Charter Communications Inc / Illumina Inc / Bio-Techne Corp / Intuitive Surgical Inc / Cheesecake Factory Inc / Plug Power Inc / Hologic Inc / Merit Medical Systems Inc / Arch Capital Group Ltd / Equinix Inc / Exact Sciences Corp / Netflix Inc / Bruker Corp / Nexstar Media Group Inc / Apollo Investment Corp / NuVasive Inc / ViacomCBS Inc / Restaurant Brands International Inc / Dexcom Inc / Discovery Inc / BJ's Restaurants Inc / Consolidated Communications Holdings Inc / Calumet Specialty Products Partners LP / Cogent Communications Holdings Inc / TransDigm Group Inc / Insulet Corp / BlackRock Capital Investment Corp / Tandem Diabetes Care Inc / W R Berkley Corp / Trinity Capital Inc / Jack in the Box Inc / Pulmonx Corp / Gibson Energy Inc / AMC Networks Inc / Angi Inc / SLM Corp / BlackRock TCP Capital Corp / Globus Medical Inc / United Insurance Holdings Corp / Fox Corp / Hemisphere Media Group Inc / Nevro Corp / Invitae Corp / Glaukos Corp / Cable One Inc / Zimmer Biomet Holdings Inc / Natera Inc / Tegna Inc / SeaSpine Holdings Corp / Novocure Ltd / T-Mobile US Inc / Lions Gate Entertainment Corp / Goldman Sachs BDC Inc / Uniti Group Inc / Altice USA Inc / Brighthouse Financial Inc / Boston Omaha Corp / Roku Inc / Switch Inc / IQVIA Holdings Inc / Qiagen NV / Inspire Medical Systems Inc / Spotify Technology SA / E W Scripps Co / Barings BDC Inc / Guardant Health Inc / Axonics Inc / Shockwave Medical Inc / iHeartMedia Inc / Avantor Inc / Brookfield Infrastructure Corp / Inari Medical Inc / Outset Medical Inc / Lumen Technologies Inc / Eargo Inc / Vizio Holding Corp / Neuropace Inc / DigitalBridge Group Inc / Phillips Edison & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">July Doc Detailing Moderates; Not Likely Reflecting the Brunt of Delta</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">08/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Peer Group Analytics - Q2 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CRL-US Company reports financial results for the quarter ended June 26,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CRL / TMO / RGEN.O / SCYX.O</td><td class="leftalignment">Charles River Laboratories International Inc / Thermo Fisher Scientific Inc / Repligen Corp / SCYNEXIS Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Dropping Coverage</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AWH / MDRX=US / ICLR=US / CERN=US / CRL=US / EXAS=US / MEDP=US / AVTR=US / NTRA=US / CHNG=US / NXGN=US / NEO=US / VEEV=US / VCYT=US / HQY=US / EVH=US / TDOC=US / TRHC=US / IQV=US / SYNH=US / PSNL=US / HCAT=US / CNVY</td><td class="leftalignment">Aspira Women's Health Inc / Allscripts Healthcare Solutions Inc / ICON PLC / Cerner Corp / Charles River Laboratories International Inc / Exact Sciences Corp / Medpace Holdings Inc / Avantor Inc / Natera Inc / Change Healthcare Inc / NextGen Healthcare Inc / Neogenomics Inc / Veeva Systems Inc / Veracyte Inc / Healthequity Inc / Evolent Health Inc / Teladoc Health Inc / Tabula Rasa HealthCare Inc / IQVIA Holdings Inc / Syneos Health Inc / Personalis Inc / Health Catalyst Inc / Convey Health Solutions Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2021 Annual Report: Creightons Net Profit up 36.8%</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q2 2021: Charles River Laboratories International reports 43.7% sequential rise in Quarterly Net Profit</td><td class="leftalignment">English</td><td class="rightalignment">78</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International jumps 21.6% from 8 week low</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">ATO / BWA / CCO / COST.O / CPK / CRL / DIS / DK / EMN / FMC / GM.N / IPG / KNX / MPC / OI / OMC / OXY / PRU / SJI / WMT / ET / AUD.N / CMCSA.O / WWE / JBHT.O / BWA.N / SBGI.O / HUBG.O / SIRI.O / CHTR.O / HWM.N / DXC / MU.O / UMPQ.O / MANT.O / NFLX.O / NXST.O / VIAC.O / DISCA.O / STX.O / XPO / SAIA.O / TNDM.OQ / JACK.O / SLRC.O / AMCX.O / WDC.O / GMED.K / MPLX.K / UIHC.O / FOXA.O / USAC.K / HMTV.O / FATE.O / TSLX.K / HUBS.K / NVRO.K / QRVO.O / CABO.N / TGNA.K / EDIT.O / LGFb.N / ATUS.N / ZYME.K / CGBD.O / BOMN.O / ROKU.O / SWCH.K / EGHT.K / CDLX.O / SPOT.K / SSP.O / TPVG.K / CDAY.K / IHRT.O / MORF.O / EXC.O / VZIO.N / 100073616</td><td class="leftalignment">Atmos Energy Corp / Borgwarner Inc / Clear Channel Outdoor Holdings Inc / Costco Wholesale Corp / Chesapeake Utilities Corp / Charles River Laboratories International Inc / Walt Disney Co / Delek US Holdings Inc / Eastman Chemical Co / FMC Corp / General Motors Co / Interpublic Group of Companies Inc / Knight-Swift Transportation Holdings Inc / Marathon Petroleum Corp / O-I Glass Inc / Omnicom Group Inc / Occidental Petroleum Corp / Prudential Financial Inc / South Jersey Industries Inc / Walmart Inc / Energy Transfer LP / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / J B Hunt Transport Services Inc / Borgwarner Inc / Sinclair Broadcast Group Inc / Hub Group Inc / Sirius XM Holdings Inc / Charter Communications Inc / Howmet Aerospace Inc / DXC Technology Co / Micron Technology Inc / Umpqua Holdings Corp / ManTech International Corp / Netflix Inc / Nexstar Media Group Inc / ViacomCBS Inc / Discovery Inc / Seagate Technology Holdings PLC / XPO Logistics Inc / Saia Inc / Tandem Diabetes Care Inc / Jack in the Box Inc / SLR Investment Corp / AMC Networks Inc / Western Digital Corp / Globus Medical Inc / MPLX LP / United Insurance Holdings Corp / Fox Corp / USA Compression Partners LP / Hemisphere Media Group Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Nevro Corp / Qorvo Inc / Cable One Inc / Tegna Inc / Editas Medicine Inc / Lions Gate Entertainment Corp / Altice USA Inc / Zymeworks Inc / TCG BDC Inc / Boston Omaha Corp / Roku Inc / Switch Inc / 8x8 Inc / Cardlytics Inc / Spotify Technology SA / E W Scripps Co / Triplepoint Venture Growth BDC Corp / Ceridian HCM Holding Inc / iHeartMedia Inc / Morphic Holding Inc / Exelon Corp / Vizio Holding Corp / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Post-Call Model Adjustments; Increasing Estimates as Unprecedented Demand Rolls On</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III / Justin Lin</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Charles River Laboratories : 2Q21 Review: Beat and Raise Quarter Shows Resilience of Portfolio: Reiterate Overweight; PT to $440</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">MARKET ANALYSIS / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tycho W. Peterson / Mr. Casey Woodring / Julia Qin</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Beat, Raise, Repeat</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">CRL: Banking the 2Q Beat; Guidance Raised for the Year</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CRL</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">HY Healthcare Check-Up : Wednesday, August 4 Roundup</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">DVA.N / CRL.N / SGRY.O</td><td class="leftalignment">DaVita Inc / Charles River Laboratories International Inc / Surgery Partners Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS</td><td class="leftalignment">David Common / Mr. Bradley H. Cobb</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2Q Rev/EPS beats; FY21 Org Rev/EPS Guides Raised</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Brief of Charles River Laboratories International Inc conference call, Aug. 04, 2021 / 9:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Aug. 04, 2021 / 9:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First Look at Second-Quarter Results; Unprecedented Demand Driving Additional Guidance Increase</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III / Justin Lin</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">A / AME / AON / AWR / BIO / BP.N / CCO / CHD / CL / CLX / CRL / DD / DGX / DHR / DIS / EL / HD / HEP / IPG / KMB / KO / LH / LOW / MCHP.O / MTD / OLN / OMC / PCG / PEG / PG / PKI / PSX / RNG / SEE / SPB / STZ / TAP.N / TMO / WAT / WLK / AUD.N / CMCSA.O / WWE / EPC / TRP.TO / SBGI.O / ICLR.O / SIRI.O / SGMO.O / CHTR.O / ILMN.O / EXPD.O / TECH.O / MNST.O / HOLX.O / BLUE.O / EXAS.O / NFLX.O / BRKR.O / NXST.O / VIAC.O / DENN.O / DISCA.O / ZIOP.O / LUNG.O / AMCX.O / FOXA.O / COTY.K / HMTV.O / LDOS.N / FATE.O / QURE.O / AGTC.O / SHLX.K / NVTA.N / UNVR.K / CABO.N / ZBH / NTRA.O / TGNA.K / CYAD.O / OMF / VYGR.O / IONS.O / WLTW.O / ADAP.O / NTLA.O / CRSP.O / LGFb.N / CLLS.O / ATUS.N / ZYME.K / IOVA.O / BOMN.O / ROKU.O / IQV / PEP.O / QGEN.K / INSP.K / SPOT.K / SSP.O / KDP.N / AUTL.O / GH.O / NWL.O / LHX.N / IHRT.O / AVTR.K / PGEN.O / BEAM.O / LUMN.K / GRCL.O / VZIO.N / BBWI.N / VSCO.N</td><td class="leftalignment">Agilent Technologies Inc / AMETEK Inc / Aon PLC / American States Water Co / Bio Rad Laboratories Inc / BP PLC / Clear Channel Outdoor Holdings Inc / Church & Dwight Co Inc / Colgate-Palmolive Co / Clorox Co / Charles River Laboratories International Inc / Dupont De Nemours Inc / Quest Diagnostics Inc / Danaher Corp / Walt Disney Co / Estee Lauder Companies Inc / Home Depot Inc / Holly Energy Partners LP / Interpublic Group of Companies Inc / Kimberly-Clark Corp / Coca-Cola Co / Laboratory Corporation of America Holdings / Lowe's Companies Inc / Microchip Technology Inc / Mettler-Toledo International Inc / Olin Corp / Omnicom Group Inc / PG&E Corp / Public Service Enterprise Group Inc / Procter & Gamble Co / PerkinElmer Inc / Phillips 66 / RingCentral Inc / Sealed Air Corp / Spectrum Brands Holdings Inc / Constellation Brands Inc / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Waters Corp / Westlake Chemical Corp / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Edgewell Personal Care Co / TC Energy Corp / Sinclair Broadcast Group Inc / ICON PLC / Sirius XM Holdings Inc / Sangamo Therapeutics Inc / Charter Communications Inc / Illumina Inc / Expeditors International of Washington Inc / Bio-Techne Corp / Monster Beverage Corp / Hologic Inc / bluebird bio Inc / Exact Sciences Corp / Netflix Inc / Bruker Corp / Nexstar Media Group Inc / ViacomCBS Inc / Denny's Corp / Discovery Inc / ZIOPHARM Oncology Inc / Pulmonx Corp / AMC Networks Inc / Fox Corp / Coty Inc / Hemisphere Media Group Inc / Leidos Holdings Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Shell Midstream Partners LP / Invitae Corp / Univar Solutions Inc / Cable One Inc / Zimmer Biomet Holdings Inc / Natera Inc / Tegna Inc / Celyad Oncology SA / OneMain Holdings Inc / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Willis Towers Watson PLC / Adaptimmune Therapeutics PLC / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Lions Gate Entertainment Corp / Cellectis SA / Altice USA Inc / Zymeworks Inc / Iovance Biotherapeutics Inc / Boston Omaha Corp / Roku Inc / IQVIA Holdings Inc / PepsiCo Inc / Qiagen NV / Inspire Medical Systems Inc / Spotify Technology SA / E W Scripps Co / Keurig Dr Pepper Inc / Autolus Therapeutics PLC / Guardant Health Inc / Newell Brands Inc / L3harris Technologies Inc / iHeartMedia Inc / Avantor Inc / Precigen Inc / Beam Therapeutics Inc / Lumen Technologies Inc / Gracell Biotechnologies Inc / Vizio Holding Corp / Bath & Body Works Inc / Victoria's Secret & Co</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CRL: 2Q EPS Ahead; 2021 Guide Raise Points to Better than Expected 2H Momentum</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Katie A. Tryhane</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools & Diagnostics: Assumption of Coverage</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">CNTG.OQ / AVTR.N / TMO.N / DHR.N / CRL.N / IDXX.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / CHWY.N / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Centogene NV / Avantor Inc / Thermo Fisher Scientific Inc / Danaher Corp / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Chewy Inc / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Katie A. Tryhane</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for CRL</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Guides De-risked, COVID Testers Investable Again?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: August 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AIRP.PA / ALB.N / ALK.N / AXP.N / BA.N / BAC.N / BAX.N / BDX.N / C.N / CCL.N / CI.N / COF.N / CRM.N / DAL.N / FCX.N / GM.N / GPS.N / JNJ.N / JPM.N / KMB.N / LLY.N / LSI.N / LUV.N / MDT.N / MO.N / NEM.N / PFE.N / PM.N / SC.N / T.N / TMO.N / U.N / WAT.N / WFC.N / PG.N / NUE.N / CPB.N / W.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / D.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / DVN.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / PKI.N / VZ.N / WST.N / MUR.N / KSS.N / ORCL.N / PWR.N / COG.N / EFX.N / V.N / EW.N / CPT.N / HWM.N / ACN.N / PLD.N / CHD.N / AIV.N / HAE.N / MKC.N / MAA.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / MHK.N / GME.N / INTC.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / ATVI.OQ / MSFT.OQ / PBCT.OQ / TEAM.OQ / REGN.OQ / SIVB.OQ / QDEL.OQ / CACC.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / GILD.OQ / DFS.N / COST.OQ / CPRT.OQ / INCY.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / TPR.N / NBIX.OQ / CTXS.OQ / AMZN.OQ / MANH.OQ / NVDA.OQ / BMRN.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / EXAS.OQ / ALGN.OQ / VRTX.OQ / JBLU.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / TFC.N / ACAD.OQ / CG.TO / DPZ.N / MOS.N / DLR.N / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / STX.AX / MA.N / IVZ.N / TDC.N / MRNA.OQ / MSCI.N / AVGO.OQ / FTNT.OQ / MU.OQ / GNRC.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / EPAM.N / SPLK.OQ / PSX.N / SRPT.OQ / GMED.N / ALLY.N / PRGO.N / COTY.N / COMM.OQ / NCLH.N / GOOGL.OQ / SAGE.OQ / HUBS.N / WBA.OQ / TDOC.N / PYPL.OQ / GBT.OQ / IONS.OQ / RETA.OQ / COUP.OQ / LW.N / AYX.N / DXC.N / CVNA.N / IOVA.OQ / AXON.OQ / WDAY.OQ / ROKU.OQ / BKNG.OQ / CBRE.N / FB.PS / CPRI.N / NFE.OQ / PINS.N / FSLY.N / CRWD.OQ / RTX.N / LMND.N / GOCO.OQ / CVAC.OQ / AMWL.N / PLTR.N / VTRS.OQ / TSP.OQ / HON.OQ</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Citigroup Inc / Carnival Corp / Cigna Corp / Capital One Financial Corp / Salesforce.Com Inc / Delta Air Lines Inc / Freeport-McMoRan Inc / General Motors Co / Gap Inc / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Life Storage Inc / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Newmont Corporation / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Wayfair Inc / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Dominion Energy Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / PerkinElmer Inc / Verizon Communications Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Kohls Corp / Oracle Corp / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Camden Property Trust / Howmet Aerospace Inc / Accenture PLC / Prologis Inc / Church & Dwight Co Inc / Apartment Investment and Management Co / Haemonetics Corp / McCormick & Company Inc / Mid-America Apartment Communities Inc / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Mohawk Industries Inc / GameStop Corp / Intel Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Activision Blizzard Inc / Microsoft Corp / People's United Financial Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / SVB Financial Group / Quidel Corp / Credit Acceptance Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Costco Wholesale Corp / Copart Inc / Incyte Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Tapestry Inc / Neurocrine Biosciences Inc / Citrix Systems Inc / Amazon.com Inc / Manhattan Associates Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Exact Sciences Corp / Align Technology Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Mosaic Co / Digital Realty Trust Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Invesco Ltd / Teradata Corp / Moderna Inc / MSCI Inc / Broadcom Inc / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Epam Systems Inc / Splunk Inc / Phillips 66 / Sarepta Therapeutics Inc / Globus Medical Inc / Ally Financial Inc / Perrigo Company PLC / Coty Inc / CommScope Holding Company Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Iovance Biotherapeutics Inc / Axon Enterprise Inc / Workday Inc / Roku Inc / Booking Holdings Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / New Fortress Energy Inc / Pinterest Inc / Fastly Inc / CrowdStrike Holdings Inc / Raytheon Technologies Corp / Lemonade Inc / Gohealth Inc / CureVac NV / American Well Corp / Palantir Technologies Inc / Viatris Inc / TuSimple Holdings Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / France / United Kingdom / Ireland / Luxembourg / Netherlands / Panama / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International jumps 20.7% from 7 week low</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">The Business Research Company</td><td class="leftalignment">Charles River Laboratories International, Inc. (Charles River) Company Briefing (COVID 19 Update)</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Department of Research</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - Growing faster for longer; Raise TP to SFr750 and reiterate Outperform</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">LONN.S / A.N / RECI.MI / TMO.N / DHR.N / LUN.CO / MRCG.DE / SATG.DE / PKI.N / BANB.S / CRL.N / UCB.BR / SFZN.S / IPN.PA / ORNBV.HE / GXIG.DE / ALM.MC / GRLS.MC / MRNA.OQ / 068270.KS / CTLT.N / PINFRAL.MX / 207940.KS / 2269.HK / GMAB.CO / PPGN.S</td><td class="leftalignment">Lonza Group AG / Agilent Technologies Inc / Recordati Industria Chimica e Farmaceutica SpA / Thermo Fisher Scientific Inc / Danaher Corp / H Lundbeck A/S / Merck KGaA / Sartorius AG / PerkinElmer Inc / Bachem Holding AG / Charles River Laboratories International Inc / Ucb SA / Siegfried Holding AG / Ipsen SA / Orion Oyj / Gerresheimer AG / Almirall SA / Grifols SA / Moderna Inc / Celltrion Inc / Catalent Inc / Promotora y Operadora de Infraestructura SAB de CV / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / Genmab A/S / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / Italy / Korea, Republic of / Mexico / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr Matthew J. Weston / Ms Jo Walton / Elizabeth Walton / Mr. Dominic Lunn / European Pharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQV: Diagnosing 2Q: Momentum Sustained; Positive CRO Bankshots</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">IQV.N / DGX.N / AZN.L / ROG.S / NOVOB.CO / LH.N / LONN.S / WST.N / CRL.N / ICLR.OQ / CTLT.N / MEDP.OQ / SYNH.OQ / CERT.OQ</td><td class="leftalignment">IQVIA Holdings Inc / Quest Diagnostics Inc / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Laboratory Corporation of America Holdings / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ICLR-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ICLR.O / CRL / SCYX.O / RDUS.O / CTLT.K</td><td class="leftalignment">ICON PLC / Charles River Laboratories International Inc / SCYNEXIS Inc / Radius Health Inc / Catalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Carel Industries strengthens 2.5% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Comet Resources lifts 11% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">DHR: Diagnosing 2Q: Impressive, Broad-Based Momentum Increases Conviction</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">DHR.N / A.N / TMO.N / WAT.N / MTD.N / PKI.N / CRL.N / BRKR.OQ / CTLT.N / AVTR.N / MRVI.OQ</td><td class="leftalignment">Danaher Corp / Agilent Technologies Inc / Thermo Fisher Scientific Inc / Waters Corp / Mettler-Toledo International Inc / PerkinElmer Inc / Charles River Laboratories International Inc / Bruker Corp / Catalent Inc / Avantor Inc / Maravai LifeSciences Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BANB.S: Bachem Holding - Favourable FDA drug approvals in 1H21</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BANB.S / A.N / TMO.N / LONN.S / CRL.N / SFZN.S / 068270.KS / CTLT.N / PINFRAL.MX / 207940.KS / 2269.HK / PPGN.S</td><td class="leftalignment">Bachem Holding AG / Agilent Technologies Inc / Thermo Fisher Scientific Inc / Lonza Group AG / Charles River Laboratories International Inc / Siegfried Holding AG / Celltrion Inc / Catalent Inc / Promotora y Operadora de Infraestructura SAB de CV / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Korea, Republic of / Mexico / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Fr. Barbora Blaha / Herr. Christoph Gretler</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Life Science & Diagnostics : 2Q21 Preview: Focus Is on Variants, Base Recovery, Inflation and Any Incremental 2022 Commentary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">A.N / ADPT.O / TMO.N / WAT.N / DGX.N / DHR.N / ICLR.O / LH.N / MTD.N / PKI.N / ILMN.O / ISRG.O / CRL.N / OSUR.O / HOLX.O / RGEN.O / QDEL.O / BRKR.O / QGEN.N / NSTG.O / CTLT.N / NTRA.O / IQV.N / GH.O / TWST.O / AVTR.N / TXG.O / BLI.O / SHC.O / AKYA.O / ZY.O / OMIC.O</td><td class="leftalignment">Agilent Technologies Inc / Adaptive Biotechnologies Corp / Thermo Fisher Scientific Inc / Waters Corp / Quest Diagnostics Inc / Danaher Corp / ICON PLC / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Illumina Inc / Intuitive Surgical Inc / Charles River Laboratories International Inc / OraSure Technologies Inc / Hologic Inc / Repligen Corp / Quidel Corp / Bruker Corp / Qiagen NV / NanoString Technologies Inc / Catalent Inc / Natera Inc / IQVIA Holdings Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / 10X Genomics Inc / Berkeley Lights Inc / Sotera Health Co / Akoya Biosciences Inc / Zymergen Inc / Singular Genomics Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Chemicals / Healthcare / Industrial Materials / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">MARKET ANALYSIS / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / SMALL CAPITAL / MORNING COMMENTS / PORTFOLIO STRATEGY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tycho W. Peterson / Julia Qin / Mr. Casey Woodring</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Contract Research Organizations: State of the CRO Industry: Sustained Healthy Biotech Funding; CT.gov Analysis; CRO Deal Activity Update</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">CRL.N / IQV.N / PFE.N / TMO.N / DGX.N / LH.N / WST.N / ICLR.OQ / CTLT.N / MEDP.OQ / SYNH.OQ / CERT.OQ</td><td class="leftalignment">Charles River Laboratories International Inc / IQVIA Holdings Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / West Pharmaceutical Services Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">A / AMT / BIO / BK / BXP / CCI / CCO / CLR / CRL / CUZ / DGX / DHR / DIS / HIW / HPP / INTC.O / IPG / KRC / LH / MS / MTD / OFC / OMC / PGR / PKI / SLG / SPB / T / TAP.N / TMO / WAT / WRE / ASML.O / AUD.N / CMCSA.O / WWE / SBGI.O / ICLR.O / SBAC.O / SIRI.O / DEI / VZ / CHTR.O / ILMN.O / TECH.O / CAKE.O / HOLX.O / PROG.O / EXAS.O / NFLX.O / BRKR.O / NXST.O / VIAC.O / DENN.O / QSR / DISCA.O / BJRI.O / STX.O / AMCX.O / WDC.O / PDCE.O / FOXA.O / HMTV.O / ESRT.K / NVRO.K / NVTA.N / CABO.N / NTRA.O / TGNA.K / PGRE.K / NVCR.O / TMUS.O / COUP.O / LGFb.N / ATUS.N / BOMN.O / ROKU.O / IQV / QGEN.K / SPOT.K / SSP.O / GH.O / IHRT.O / AVTR.K / VZIO.N</td><td class="leftalignment">Agilent Technologies Inc / American Tower Corp / Bio Rad Laboratories Inc / Bank of New York Mellon Corp / Boston Properties Inc / Crown Castle International Corp / Clear Channel Outdoor Holdings Inc / Continental Resources Inc / Charles River Laboratories International Inc / Cousins Properties Inc / Quest Diagnostics Inc / Danaher Corp / Walt Disney Co / Highwoods Properties Inc / Hudson Pacific Properties Inc / Intel Corp / Interpublic Group of Companies Inc / Kilroy Realty Corp / Laboratory Corporation of America Holdings / Morgan Stanley / Mettler-Toledo International Inc / Corporate Office Properties Trust / Omnicom Group Inc / Progressive Corp / PerkinElmer Inc / SL Green Realty Corp / Spectrum Brands Holdings Inc / AT&T Inc / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Waters Corp / Washington Real Estate Investment Trust / ASML Holding NV / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Sinclair Broadcast Group Inc / ICON PLC / SBA Communications Corp / Sirius XM Holdings Inc / Douglas Emmett Inc / Verizon Communications Inc / Charter Communications Inc / Illumina Inc / Bio-Techne Corp / Cheesecake Factory Inc / Hologic Inc / Progenity Inc / Exact Sciences Corp / Netflix Inc / Bruker Corp / Nexstar Media Group Inc / ViacomCBS Inc / Denny's Corp / Restaurant Brands International Inc / Discovery Inc / BJ's Restaurants Inc / Seagate Technology Holdings PLC / AMC Networks Inc / Western Digital Corp / PDC Energy Inc / Fox Corp / Hemisphere Media Group Inc / Empire State Realty Trust Inc / Nevro Corp / Invitae Corp / Cable One Inc / Natera Inc / Tegna Inc / Paramount Group Inc / Novocure Ltd / T-Mobile US Inc / Coupa Software Inc / Lions Gate Entertainment Corp / Altice USA Inc / Boston Omaha Corp / Roku Inc / IQVIA Holdings Inc / Qiagen NV / Spotify Technology SA / E W Scripps Co / Guardant Health Inc / iHeartMedia Inc / Avantor Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SFZN.S: Siegfried Holding - Increased seasonality due to cyber attack</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">SFZN.S / A.N / TMO.N / LONN.S / BANB.S / CRL.N / 068270.KS / CTLT.N / 207940.KS / 2269.HK / PPGN.S</td><td class="leftalignment">Siegfried Holding AG / Agilent Technologies Inc / Thermo Fisher Scientific Inc / Lonza Group AG / Bachem Holding AG / Charles River Laboratories International Inc / Celltrion Inc / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Fr. Barbora Blaha / Herr. Christoph Gretler</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Bioprocess Has Years to Run, Alzheimer’s or Not</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / PROG.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Progenity Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">A / ABT / AXP / BA.N / BIO / COF / CRL / DGX / DHR / GD / LH / MA / MTD / PKI / RKT / RRC / TMO / V / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / PROG.O / EXAS.O / BRKR.O / TDG.N / CACI.N / PFSI.K / FOXA.O / LDOS.N / NVTA.N / NTRA.O / CDEV.O / IQV / QGEN.K / GH.O / AVTR.K / RTX.N / HMPT.O / AOMR.N / WKME.O</td><td class="leftalignment">Agilent Technologies Inc / Abbott Laboratories / American Express Co / Boeing Co / Bio Rad Laboratories Inc / Capital One Financial Corp / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / General Dynamics Corp / Laboratory Corporation of America Holdings / Mastercard Inc / Mettler-Toledo International Inc / PerkinElmer Inc / Rocket Companies Inc / Range Resources Corp / Thermo Fisher Scientific Inc / Visa Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Progenity Inc / Exact Sciences Corp / Bruker Corp / TransDigm Group Inc / CACI International Inc / PennyMac Financial Services Inc / Fox Corp / Leidos Holdings Inc / Invitae Corp / Natera Inc / Centennial Resource Development Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc / Raytheon Technologies Corp / Home Point Capital Inc / Angel Oak Mortgage Inc / Walkme Ltd</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Doc Detailing Steps up with Summer</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / PROG.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Progenity Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2Q Healthcare Tech & Distribution Preview + 10am Webinar: Where Do We Go from He</td><td class="leftalignment">English</td><td class="rightalignment">73</td><td class="leftalignment">US1598641074 / IE0005711209 / US1266501006 / US14149Y1082 / US1567821046 / US58155Q1031 / US7677541044 / US8064071025 / US0162551016 / US03073E1055 / US7033951036 / US28238P1093 / US9314271084 / US87918A1051 / US24906P1093 / US46266C1053 / US87166B1026 / US29415F1049 / US68269G1076 / US8163073005 / US67181A1079 / GOCO US</td><td class="leftalignment">Charles River Laboratories International Inc / ICON PLC / CVS Health Corp / Cardinal Health Inc / Cerner Corp / Mckesson Corp / Rite Aid Corp / Henry Schein Inc / Align Technology Inc / Amerisourcebergen Corp / Patterson Companies Inc / eHealth Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / DENTSPLY SIRONA Inc / IQVIA Holdings Inc / Syneos Health Inc / Envista Holdings Corp / 1Life Healthcare Inc / SelectQuote Inc / Oak Street Health Inc / Gohealth Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Lower for Life Sciences (2H June); Highlighting ALGN and MRVI</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ALGN.OQ / MRVI.OQ / BDX.N / TMO.N / WAT.N / DGX.N / DHR.N / LH.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / ILMN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / PINFRAL.MX / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Align Technology Inc / Maravai LifeSciences Holdings Inc / Becton Dickinson and Co / Thermo Fisher Scientific Inc / Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Illumina Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Promotora y Operadora de Infraestructura SAB de CV / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Mexico / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">A / AIG / AJG / ALL / AON / AR / ASH / BIO / BMY / CB / CLR / CNI / CNX / COG / CP / CPE / CRL / DGX / DHR / DVN / EOG / EQT / HIG / JNJ / LH / LNC / MET / MGY / MMC / MRO / MTD / NSC / PGR / PKI / PPG / PRU / PXD / RE / RNR / RRC / SM / SWN / TMO / TRV / UNP / WAT / WLL / CMCSA.O / BRO / ENB.TO / ICLR.O / CHTR.O / ILMN.O / TECH.O / AXS / LPI / HOLX.O / PROG.O / BLUE.O / ACGL.O / EXAS.O / BRKR.O / NOG.A / WRB.N / TSLA.O / ESTE.K / MTDR.K / PDCE.O / FANG.O / UIHC.O / BCEI.K / VOYA.K / FATE.O / NVTA.N / CABO.N / NTRA.O / CYAD.O / CSX.O / WLTW.O / CRSP.O / CLLS.O / CDEV.O / ATUS.N / BHF.O / IQV / QGEN.K / EQH / AUTL.O / BRY.O / GH.O / AVTR.K / BRP.O / OAS.O / NTST.K / ROOT.O / GRCL.O / CHK.O</td><td class="leftalignment">Agilent Technologies Inc / American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / Aon PLC / Antero Resources Corp / Ashland Global Holdings Inc / Bio Rad Laboratories Inc / Bristol-Myers Squibb Co / Chubb Ltd / Continental Resources Inc / Canadian National Railway Co / CNX Resources Corp / Coterra Energy Inc / Canadian Pacific Railway Ltd / Callon Petroleum Co / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Johnson & Johnson / Laboratory Corporation of America Holdings / Lincoln National Corp / MetLife Inc / Magnolia Oil & Gas Corp / Marsh & McLennan Companies Inc / Marathon Oil Corp / Mettler-Toledo International Inc / Norfolk Southern Corp / Progressive Corp / PerkinElmer Inc / PPG Industries Inc / Prudential Financial Inc / Pioneer Natural Resources Co / Everest Re Group Ltd / Renaissancere Holdings Ltd / Range Resources Corp / SM Energy Co / Southwestern Energy Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Union Pacific Corp / Waters Corp / Whiting Petroleum Corp / Comcast Corp / Brown & Brown Inc / Enbridge Inc / ICON PLC / Charter Communications Inc / Illumina Inc / Bio-Techne Corp / AXIS Capital Holdings Ltd / Laredo Petroleum Inc / Hologic Inc / Progenity Inc / bluebird bio Inc / Arch Capital Group Ltd / Exact Sciences Corp / Bruker Corp / Northern Oil and Gas Inc / W R Berkley Corp / Tesla Inc / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / United Insurance Holdings Corp / Civitas Resources Inc / Voya Financial Inc / Fate Therapeutics Inc / Invitae Corp / Cable One Inc / Natera Inc / Celyad Oncology SA / CSX Corp / Willis Towers Watson PLC / CRISPR Therapeutics AG / Cellectis SA / Centennial Resource Development Inc / Altice USA Inc / Brighthouse Financial Inc / IQVIA Holdings Inc / Qiagen NV / Equitable Holdings Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Guardant Health Inc / Avantor Inc / BRP Group Inc / Oasis Petroleum Inc / Netstreit Corp / Root Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Déjà vu: Core Will Crush It, COVID Needs to Come Down</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / PROG.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Progenity Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: CRL - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CRL</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: July 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / AL.N / ALK.N / AXP.N / BA.N / BAC.N / BDX.N / C.N / CL.N / COF.N / CRM.N / CVS.N / DAL.N / ECL.N / EIX.N / EOG.N / F.N / GPS.N / IBM.N / JPM.N / KO.N / LLY.N / LUV.N / MO.N / OXY.N / PFE.N / PM.N / SC.N / SEE.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / CPB.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / DE.N / CAT.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / BLL.N / VZ.N / NYT.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / NEU.N / EFX.N / EQT.N / V.N / ACN.N / WSM.N / ESI.N / HAE.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / FISV.OQ / HOLX.OQ / HBAN.OQ / LRCX.OQ / MSFT.OQ / ROL.N / THO.N / ALKS.OQ / QDEL.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / COST.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / CSGP.OQ / ERIE.OQ / NVDA.OQ / FFIV.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / GPN.N / VRTX.OQ / JBLU.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / TFC.N / SBNY.OQ / ACAD.OQ / CG.TO / DPZ.N / MKTX.OQ / LVS.N / DISCA.OQ / MS.N / STX.AX / RPRX.OQ / HES.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / LOPE.OQ / MSCI.N / VRSK.OQ / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / APO.N / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / ADT.N / FANG.OQ / BFAM.N / RNG.N / COMM.OQ / MAR.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / BWXT.K / PEN.N / NVCR.OQ / TMUS.OQ / IONS.OQ / IAC.OQ / NTNX.OQ / RETA.OQ / COUP.OQ / AYX.N / DXC.N / IOVA.OQ / WDAY.OQ / ROKU.OQ / SWCH.N / IQV.N / BKNG.OQ / FB.PS / UAL.OQ / STNE.OQ / FSLY.N / CRWD.OQ / PTON.OQ / NLOK.OQ / RTX.N / AMWL.N / VTRS.OQ / PLTK.OQ</td><td class="leftalignment">Abbott Laboratories / Air Lease Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Becton Dickinson and Co / Citigroup Inc / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Southwest Airlines Co / Altria Group Inc / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / Sealed Air Corp / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / New York Times Co / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / NewMarket Corp / Equifax Inc / EQT Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Element Solutions Inc / Haemonetics Corp / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Fiserv Inc / Hologic Inc / Huntington Bancshares Inc / Lam Research Corp / Microsoft Corp / Rollins Inc / Thor Industries Inc / Alkermes Plc / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Costco Wholesale Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / CoStar Group Inc / Erie Indemnity Co / NVIDIA Corp / F5 Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Grand Canyon Education Inc / MSCI Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Apollo Global Management Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / ADT Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / RingCentral Inc / CommScope Holding Company Inc / Marriott International Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / BWX Technologies Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Nutanix Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Alteryx Inc / DXC Technology Co / Iovance Biotherapeutics Inc / Workday Inc / Roku Inc / Switch Inc / IQVIA Holdings Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / StoneCo Ltd / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / American Well Corp / Viatris Inc / Playtika Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / United Kingdom / Ireland / Luxembourg / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/04/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Charles River Laboratories International Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">2021 DC Day Review: Expect Incremental Policy Reform, Strong Support for Value-Based Care, Tech-Enabled Novel Delivery Models</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 09060J106 / 252131107 / 42222N103 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 90184D100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 88025U109 / 30068X103 / 15912K100 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107 / 98985X100</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Mr. Raju Prasad, PHD / John C. Kreger, III / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / Brian D. Weinstein, CFA / Mr. Tim F. Lugo / Mr. Matt Larew / Matt Phipps, PHD / Mr. Myles R. R. Minter</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Charles River Laboratories International Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Creightons PLC</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Agriculture / Beverages & Tobacco / Consumer / Cosmetics & Personal Care / Food / Household Products / Retailing / Services</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Charles River Laboratories International in top 8% performers of NYSE market in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">77</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International surges 28% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Comet Resources plunges 70% on a four-year slippery slope, down 6% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Charles River Laboratories International, Inc. JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Final Reminder: Virtual Washington, D.C. Day - This Wednesday, June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Charles River Laboratories International, Inc.(CRL) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Higher for Life Sciences (1H June); Highlighting ZTS and IQV</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">A.N / BDX.N / TMO.N / WAT.N / DGX.N / DHR.N / LH.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / ILMN.OQ / ALGN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Agilent Technologies Inc / Becton Dickinson and Co / Thermo Fisher Scientific Inc / Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Illumina Inc / Align Technology Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">CROs/ABC - Bbrg Reports Parexel for Sale at 20x EBITDA</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US03073E1055 / IE0005711209 / US1598641074 / US46266C1053 / US87166B1026</td><td class="leftalignment">Amerisourcebergen Corp / ICON PLC / Charles River Laboratories International Inc / IQVIA Holdings Inc / Syneos Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International up 8% from 2 week low</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: CRL - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CRL</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Carel Industries Revenue up 1.3%</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Reminder: Virtual Washington, D.C. Day - June 30, 2021; Updated Full Agenda</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">228</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Creightons gains 8.3% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">A / AJG / AME / AZO / BAC / BIO / CMG / CMS / CRL / DGX / DHI / DHR / DOW / DVN / EL / FDX / FOR / GPS / JNJ / KBH / KEY / LEN / LH / MA / MDC / MDT / MTD / MTH / NSC / NVR / OKE / OLN / PHM.N / PKI / PRU / SO / SYY / TMO / TOL / TPH / WAT / WES / TROW.O / AMZN.O / ET / AAPL.O / CSCO.O / ICLR.O / ODFL.O / SBUX.O / SNPS.O / EXPE.O / ILMN.O / TECH.O / DXC / CAKE.O / HOLX.O / PROG.O / ACGL.O / EXAS.O / BRKR.O / SBNY.O / PLAY.O / QSR / BJRI.O / XPO / SAIA.O / CCS.N / NXPI.O / STAG.K / FB.O / TRGP.K / MPLX.K / TMHC.K / MAR.O / LGIH.O / GOOGL.O / QRVO.O / NVTA.N / CABO.N / ZBH / NTRA.O / PFGC.K / CVNA.K / IQV / QGEN.K / CDLX.O / GH.O / SWAV.O / UBER.K / AVTR.K / VRM.O / SFT.O</td><td class="leftalignment">Agilent Technologies Inc / Arthur J Gallagher & Co / AMETEK Inc / Autozone Inc / Bank of America Corp / Bio Rad Laboratories Inc / Chipotle Mexican Grill Inc / CMS Energy Corp / Charles River Laboratories International Inc / Quest Diagnostics Inc / D R Horton Inc / Danaher Corp / Dow Inc / Devon Energy Corp / Estee Lauder Companies Inc / FedEx Corp / Forestar Group Inc / Gap Inc / Johnson & Johnson / KB Home / KeyCorp / Lennar Corp / Laboratory Corporation of America Holdings / Mastercard Inc / MDC Holdings Inc / Medtronic PLC / Mettler-Toledo International Inc / Meritage Homes Corp / Norfolk Southern Corp / NVR Inc / ONEOK Inc / Olin Corp / Pultegroup Inc / PerkinElmer Inc / Prudential Financial Inc / Southern Co / Sysco Corp / Thermo Fisher Scientific Inc / Toll Brothers Inc / Tri Pointe Homes Inc (Delaware) / Waters Corp / Western Midstream Partners LP / T Rowe Price Group Inc / Amazon.com Inc / Energy Transfer LP / Apple Inc / Cisco Systems Inc / ICON PLC / Old Dominion Freight Line Inc / Starbucks Corp / Synopsys Inc / Expedia Group Inc / Illumina Inc / Bio-Techne Corp / DXC Technology Co / Cheesecake Factory Inc / Hologic Inc / Progenity Inc / Arch Capital Group Ltd / Exact Sciences Corp / Bruker Corp / Signature Bank / Dave & Buster's Entertainment Inc / Restaurant Brands International Inc / BJ's Restaurants Inc / XPO Logistics Inc / Saia Inc / Century Communities Inc / NXP Semiconductors NV / STAG Industrial Inc / Meta Platforms Inc / Targa Resources Corp / MPLX LP / Taylor Morrison Home Corp / Marriott International Inc / LGI Homes Inc / Alphabet Inc / Qorvo Inc / Invitae Corp / Cable One Inc / Zimmer Biomet Holdings Inc / Natera Inc / Performance Food Group Co / Carvana Co / IQVIA Holdings Inc / Qiagen NV / Cardlytics Inc / Guardant Health Inc / Shockwave Medical Inc / Uber Technologies Inc / Avantor Inc / Vroom Inc / Shift Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Carl Data Solutions Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Electronics / Info. Tech./Software / Technology</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Doc Detailing Remains Muted but Improving</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / PROG.O / EXAS.O / BRKR.O / NVTA.N / NTRA.O / IQV / QGEN.K / GH.O / AVTR.K</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Progenity Inc / Exact Sciences Corp / Bruker Corp / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Qiagen NV / Guardant Health Inc / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">DHR: Bolsters Position in High-Growth Genomic Medicines Landscape with $10B Aldevron Deal</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">DHR.N / GE.N / TMO.N / CRL.N / CTLT.N / AVTR.N / MRVI.OQ</td><td class="leftalignment">Danaher Corp / General Electric Co / Thermo Fisher Scientific Inc / Charles River Laboratories International Inc / Catalent Inc / Avantor Inc / Maravai LifeSciences Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for CRL. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Reminder: Virtual Washington, D.C. Day - June 30, 2021; Full Agenda Now Available</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Carel Industries SpA</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment"></td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Comet Resources strengthens 4.8% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Jun. 10, 2021 / 11:20AM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ADC / AEE / AGR / ALL / AMAT.O / AME / AR / BAC / BEN / BEP / BLK / CLR / CMS / CNP / CNX / COG / CPE / CRL / CUZ / DHR / DIS / DOW / DRE / DVN / EGP / EL / EOG / EQT / ES / EXR / HES / JPM / KNX / LXP / MGY / MPC / MRO / NEP / PGR / PLD / PXD / RH / RRC / SM / SO / SWN / WLK / WLL / WPC / TEN.N / JBHT.O / NVDA.O / PEB.N / HUBG.O / CONE.O / AMD.O / HWM.N / EXPE.O / ISRG.O / LPI / DXC / NEE / LYB / EQIX.O / MANT.O / SHO.N / FSK / TDG.N / HST.N / XPO / IVZ / SAIC.N / NOG.A / CACI.N / SCHW.K / BAH.N / STAG.K / ESTE.K / MTDR.K / FB.O / PDCE.O / FANG.O / BCEI.K / PFSI.K / LDOS.N / MAR.O / XHR.N / PGRE.K / PYPL.O / CDEV.O / ORSTED.CO / VICI.K / BRY.O / SVC.O / OAS.O / NTST.K / CHK.O / NPCE.O</td><td class="leftalignment">Agree Realty Corp / Ameren Corp / Avangrid Inc / Allstate Corp / Applied Materials Inc / AMETEK Inc / Antero Resources Corp / Bank of America Corp / Franklin Resources Inc / Brookfield Renewable Partners LP / BlackRock Inc / Continental Resources Inc / CMS Energy Corp / CenterPoint Energy Inc / CNX Resources Corp / Coterra Energy Inc / Callon Petroleum Co / Charles River Laboratories International Inc / Cousins Properties Inc / Danaher Corp / Walt Disney Co / Dow Inc / Duke Realty Corp / Devon Energy Corp / Eastgroup Properties Inc / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Eversource Energy / Extra Space Storage Inc / Hess Corp / JPMorgan Chase & Co / Knight-Swift Transportation Holdings Inc / LXP Industrial Trust / Magnolia Oil & Gas Corp / Marathon Petroleum Corp / Marathon Oil Corp / Nextera Energy Partners LP / Progressive Corp / Prologis Inc / Pioneer Natural Resources Co / RH / Range Resources Corp / SM Energy Co / Southern Co / Southwestern Energy Co / Westlake Chemical Corp / Whiting Petroleum Corp / WP Carey Inc / Tenneco Inc / J B Hunt Transport Services Inc / NVIDIA Corp / Pebblebrook Hotel Trust / Hub Group Inc / CyrusOne Inc / Advanced Micro Devices Inc / Howmet Aerospace Inc / Expedia Group Inc / Intuitive Surgical Inc / Laredo Petroleum Inc / DXC Technology Co / Nextera Energy Inc / LyondellBasell Industries NV / Equinix Inc / ManTech International Corp / Sunstone Hotel Investors Inc / FS KKR Capital Corp / TransDigm Group Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / Invesco Ltd / Science Applications International Corp / Northern Oil and Gas Inc / CACI International Inc / Charles Schwab Corp / Booz Allen Hamilton Holding Corp / STAG Industrial Inc / Earthstone Energy Inc / Matador Resources Co / Meta Platforms Inc / PDC Energy Inc / Diamondback Energy Inc / Civitas Resources Inc / PennyMac Financial Services Inc / Leidos Holdings Inc / Marriott International Inc / Xenia Hotels & Resorts Inc / Paramount Group Inc / PayPal Holdings Inc / Centennial Resource Development Inc / Orsted A/S / VICI Properties Inc / Berry Corporation (Bry) / Service Properties Trust / Oasis Petroleum Inc / Netstreit Corp / Chesapeake Energy Corp / Neuropace Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Eq Strat: Please Sir, May I Have Some Mo'?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMAT.O / AME / BAC / BLK / CNP / CRL / DHR / DIS / DRE / DVN / EL / EXR / HES / JPM / MPC / PXD / NVDA.O / AMD.O / HWM.N / EXPE.O / ISRG.O / DXC / TDG.N / SCHW.K / FB.O / MAR.O / PYPL.O</td><td class="leftalignment">Applied Materials Inc / AMETEK Inc / Bank of America Corp / BlackRock Inc / CenterPoint Energy Inc / Charles River Laboratories International Inc / Danaher Corp / Walt Disney Co / Duke Realty Corp / Devon Energy Corp / Estee Lauder Companies Inc / Extra Space Storage Inc / Hess Corp / JPMorgan Chase & Co / Marathon Petroleum Corp / Pioneer Natural Resources Co / NVIDIA Corp / Advanced Micro Devices Inc / Howmet Aerospace Inc / Expedia Group Inc / Intuitive Surgical Inc / DXC Technology Co / TransDigm Group Inc / Charles Schwab Corp / Meta Platforms Inc / Marriott International Inc / PayPal Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Christopher P. Harvey / Gary S. Liebowitz, CFA / Anna Han</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Higher for Life Sciences (2H May); Highlighting AVTR and PDCO</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AVTR.N / PDCO.OQ / WAT.N / DGX.N / DHR.N / LH.N / MTD.N / PKI.N / CRL.N / IDXX.OQ / XRAY.OQ / HSIC.OQ / ALGN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Avantor Inc / Patterson Companies Inc / Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Align Technology Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PZC-GB -  Dividend Quality Analysis, for the period ended April 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PZC.L / MCB.L / PFD.L / ULVR.L / CRGT.L</td><td class="leftalignment">PZ Cussons PLC / McBride PLC / Premier Foods PLC / Unilever PLC / Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PPGN.S: PolyPeptide Grp - No. 2 peptide maker in an attractive market</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">BANB.S / PPGN.S / A.N / SOLB.BR / TMO.N / ROG.S / NOVOB.CO / LONN.S / CRL.N / SFZN.S / 068270.KS / CTLT.N / 207940.KS / 2269.HK</td><td class="leftalignment">Bachem Holding AG / PolyPeptide Group AG / Agilent Technologies Inc / Solvay SA / Thermo Fisher Scientific Inc / Roche Holding AG / Novo Nordisk A/S / Lonza Group AG / Charles River Laboratories International Inc / Siegfried Holding AG / Celltrion Inc / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Denmark / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Fr. Barbora Blaha / Herr. Christoph Gretler</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Register: Virtual Washington, D.C. Day - June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Jun. 02, 2021 / 11:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Creightons PLC</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Agriculture / Beverages & Tobacco / Consumer / Cosmetics & Personal Care / Food / Household Products / Retailing / Services</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Jun. 01, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Carel Industries surges 36% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International climbs 15.5% from 7 week low</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Investor Day Observations and Estimate Revisions; Impressive Evolution Continues</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Charles River Laboratories: All Good Things Start Somewhere: Thoughts on CRL Analyst Day</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">George R. Hill / Charlotte Kolb / Maxi Ma</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Is Comet Resources Ltd for Long-Term Investors?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Australasia</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Charles River Laboratories : Analyst Day Recap: FY21-24 Operational Targets Beat Street, While Focus Remains on High-Growth C&GT Market; Maintain OW</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">CRL.N / LH.N</td><td class="leftalignment">Charles River Laboratories International Inc / Laboratory Corporation of America Holdings</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / CAPITALIZATION / MISCELLANEOUS / CHANGE IN RECOMMENDATION / EVENT CALENDAR / MORNING COMMENTS / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tycho W. Peterson / Mr. Casey Woodring / Julia Qin</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Notes from the Road - Virtual Investor Day - Raising Estimates & PT (now $395)</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Updated 2024 Targets (upside to ST) Show Power of CRL Business 'Model'</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, May 27, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CRL: Investor Day Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Carl Data Solutions Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Electronics / Info. Tech./Software / Technology</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CRL-GB -  Dividend Quality Analysis, for the period ended January 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CRGT.L / MCB.L / ULVR.L / PZC.L</td><td class="leftalignment">Creightons PLC / McBride PLC / Unilever PLC / PZ Cussons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Save the Date - Washington, D.C. Day - June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CRL: Constructive into Investor Day on 5/27</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CRL.N / TMO.N / CTLT.N</td><td class="leftalignment">Charles River Laboratories International Inc / Thermo Fisher Scientific Inc / Catalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Charles River Laboratories International jumps 18% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">75</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / LSI=US / PFE=US / AMGN=US / BMY=US / MCD=US / WEN=US / INCY=US / CHKP=US / IART=US / MAC=US / BMRN=US / BNL=US / CBRL=US / CRL=US / DRI=US / EXEL=US / NOW=US / REGI=US / STOR=US / PSA=US / NET=US / OFC=US / SRC=US / NTRA=US / DIN=US / RPD=US / BIIB=US / EXR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / CMG=US / REX=US / GPRE=US / EHTH=US / OC=US / TAST=US / QSR=US / JACK=US / NEO=US / CUBE=US / PANW=US / ABBV=US / NDLS=US / FEYE=US / VRNS=US / 00770K202 / LOCO=US / SHAK=US / NSA=US / WING=US / LOB=US / ZS=US / LGF.B=US / OKTA=US / YEXT=US / SAIL=US / TENB=US / CRWD=US / ARQT=US / 96758W101 / VTRS=US / ABNB=US / HYFM=US / HIMS=US / KNBE=US</td><td class="leftalignment">Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Wendys Co / Incyte Corp / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Macerich Co / Biomarin Pharmaceutical Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Charles River Laboratories International Inc / Darden Restaurants Inc / Exelixis Inc / ServiceNow Inc / Renewable Energy Group Inc / STORE Capital Corp / Public Storage / Cloudflare Inc / Corporate Office Properties Trust / Spirit Realty Capital Inc / Natera Inc / Dine Brands Global Inc / Rapid7 Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / eHealth Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Neogenomics Inc / CubeSmart / Palo Alto Networks Inc / Abbvie Inc / Noodles & Co / Mandiant Inc / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / National Storage Affiliates Trust / Wingstop Inc / Live Oak Bancshares Inc / Zscaler Inc / Lions Gate Entertainment Corp / Okta Inc / Yext Inc / SailPoint Technologies Holdings Inc / Tenable Holdings Inc / CrowdStrike Holdings Inc / Arcutis Biotherapeutics Inc / WideOpenWest Inc / Viatris Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Hims & Hers Health Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">CRL Model Update</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">CRL=US</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alexander Y. Draper, CFA / Mitchell Ostrovsky</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Higher for Life Sciences (1H May); Highlighting NVST and LH</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">WAT.N / DGX.N / DHR.N / LH.N / MTD.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / ALGN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Align Technology Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Contract Research Organizations: Positive CRO Industry Vibes: A Review of the Global R&D Environment; Biotech Funding</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">CRL.N / ICLR.OQ / MEDP.OQ / IQV.N / SYNH.OQ</td><td class="leftalignment">Charles River Laboratories International Inc / ICON PLC / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Carl Data Solutions Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">05/23/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Comet Resources Limited</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Acquisition of Vigene Biosciences Marks Fourth Notable Purchase to Better Serve Cell and Gene Therapy Innovators</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Peer Group Analytics - Q1 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">CRL Scales Cognate w/Vigene Acq for $350 MM (10x revs); Tweaking up '22/'23 Ests</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CRL: Bolsters CDMO Capabilities in Cell & Gene Therapy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CRL.N / TMO.N / CTLT.N</td><td class="leftalignment">Charles River Laboratories International Inc / Thermo Fisher Scientific Inc / Catalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">05/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 5.16.21</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">ABT / ACAD / 00365410 / 28176E10 / 62855J10 / 01988P10 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 45253H10 / 12665010 / 07181310 / 10113710 / 92532F10 / 88355610 / 35802910 / 94184810 / 04635310 / 43644010 / 76115210 / 64125C10 / 87936910 / 37555810 / 15678210 / 03116210 / 66987V10 / 75886F10 / 46120E60 / M2572210 / 45232710 / 09062X10 / 01625510 / 30063P10 / 478160104 / 98956P10 / 159864107 / 640268108 / 075887109 / 02043Q10 / 67070410 / 207410101 / 205306103 / 45784P10 / 25213110 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 92337F10 / 05463X10 / 45780L10 / 92247510 / 09073M104 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 75046920 / 74587V10 / 00287Y10 / 92346J10 / 98401F10 / 46071F10 / G5960L10 / 46222210 / 18946410 / 04004760 / 04280A10 / 92686J10 / 05337M104 / 23283X20 / 40131M10 / 63230710 / 89853L10 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 90041T10 / 09627Y10 / 68071010 / Y9530810 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 87337910 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 98978L20 / 92857F10 / 04685N10 / 13089P10 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 98887Q10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 80405P10 / N4482110 / 92765F10 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 23306J10 / 34385P10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / H9060V101</td><td class="leftalignment">Abbott Laboratories / ACADIA Pharmaceuticals Inc / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / ImmunoGen Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Fresenius Medical Care AG & Co KGaA / Waters Corp / AstraZeneca PLC / Hologic Inc / Resmed Inc / Neurocrine Biosciences Inc / Teleflex Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Compugen Ltd / Illumina Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Zimmer Biomet Holdings Inc / Charles River Laboratories International Inc / Nektar Therapeutics / Becton Dickinson and Co / Alnylam Pharmaceuticals Inc / NuVasive Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / Veracyte Inc / AxoGen Inc / Inogen Inc / Veeva Systems Inc / Bio-Techne Corp / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Radius Health Inc / Puma Biotechnology Inc / Abbvie Inc / Vericel Corp / Xencor Inc / Intersect Ent Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Viking Therapeutics Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Natera Inc / T2 Biosystems Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Olink Holding AB (publ) / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Tabula Rasa HealthCare Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / Vocera Communications Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Zai Lab Ltd / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Satsuma Pharmaceuticals Inc / InflaRx NV / Viracta Therapeutics Inc / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / DBV Technologies SA / Fluidigm Corp / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / VectivBio Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Charles River Laboratories International Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Creightons PLC</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, May 12, 2021 / 10:15AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Creightons PLC</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Agriculture / Beverages & Tobacco / Consumer / Cosmetics & Personal Care / Food / Household Products / Retailing / Services</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Lower for Life Sciences (2H April); Highlighting ELAN and IQV</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ELAN.N / IQV.N / WAT.N / DGX.N / DHR.N / LH.N / MTD.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / ALGN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / SYNH.OQ / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Elanco Animal Health Inc / IQVIA Holdings Inc / Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Align Technology Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / Syneos Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools & Diagnostics: Top Questions for Management Teams</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">4502.T / BMY.N / CI.N / CVS.N / GE.N / MCK.N / MRK.N / PFE.N / TMO.N / WMT.N / DGX.N / AZN.L / ROG.S / DHR.N / UNH.N / LH.N / MMM.N / CRL.N / IDXX.OQ / XRAY.OQ / HSIC.OQ / AMZN.OQ / ALGN.OQ / STMN.S / PETS.OQ / ICLR.OQ / QGEN.N / BAYGN.DE / ZTS.N / PAHC.OQ / LNTH.OQ / ANTM.N / WBA.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / General Electric Co / Mckesson Corp / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Walmart Inc / Quest Diagnostics Inc / AstraZeneca PLC / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / 3M Co / Charles River Laboratories International Inc / IDEXX Laboratories Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Amazon.com Inc / Align Technology Inc / Straumann Holding AG / Petmed Express Inc / ICON PLC / Qiagen NV / Bayer AG / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Ireland / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">05/09/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, CRL</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Comet Resources decreases 5.0% in 2021, but outperforming Materials sector</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CRL-US Company reports financial results for the quarter ended March 27,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CRL / RGEN.O / SCYX.O</td><td class="leftalignment">Charles River Laboratories International Inc / Repligen Corp / SCYNEXIS Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Post-Call Model Adjustments; Increasing Estimates Following Very Strong Start to Year and Addition of Cognate Bio to Guidance</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Healthcare IT & Distribution: Two’fer: CRL / CTLT Results Highlight Demand Strength in Pharma Services</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CTLT.N / CRL.N</td><td class="leftalignment">Catalent Inc / Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">George R. Hill / Charlotte Kolb / Maxi Ma</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Charles River Laboratories : 1Q21 Recap: Strong Results & Guidance Raise, As Preclinical Activity Continues to Hum Along; Reiterate OW, PT to $375</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MISCELLANEOUS / CHANGE IN RECOMMENDATION / EVENT CALENDAR / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tycho W. Peterson / Ms. Eleni M. Apostolatos / Julia Qin / Mr. Casey Woodring</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">The Force is Still Strong with This one</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AM / CCO / COP / CRL / D / DIS / EL / EPD / F.N / GEL / GLP / GPS / HEP / IPG / MMP / MTH / NGL / NS / OKE / OMC / RKT / SPH / SUN / SYY / WES / WMB / ET / AUD.N / CMCSA.O / WWE / OGS / KMI / ENB.TO / TRP.TO / SBGI.O / PAA.N / SIRI.O / CHTR.O / GPN / JKHY.O / NFLX.O / NXST.O / DKL / VIAC.O / DISCA.O / CVLT.O / CQP.A / PPL.TO / KEY.TO / LNG.N / GEI.TO / AMCX.O / ANGI.O / TRGP.K / SMLP.K / MPLX.K / PFSI.K / FOXA.O / PSXP.K / USAC.K / HMTV.O / CEQP.K / SHLX.K / ENLC.K / CAPL.K / PBFX.K / CABO.N / ZBH / TGNA.K / IAC.O / LGFb.N / ATUS.N / BOMN.O / HESM.K / ROKU.O / SPOT.K / SSP.O / AVRO.O / RTLR.O / IHRT.O / ETRN.K / OMP.O / HMPT.O / 87975H100 / VZIO.N</td><td class="leftalignment">Antero Midstream Corp / Clear Channel Outdoor Holdings Inc / Conocophillips / Charles River Laboratories International Inc / Dominion Energy Inc / Walt Disney Co / Estee Lauder Companies Inc / Enterprise Products Partners LP / Ford Motor Co / Genesis Energy LP / Global Partners LP / Gap Inc / Holly Energy Partners LP / Interpublic Group of Companies Inc / Magellan Midstream Partners LP / Meritage Homes Corp / NGL Energy Partners LP / NuStar Energy LP / ONEOK Inc / Omnicom Group Inc / Rocket Companies Inc / Suburban Propane Partners LP / Sunoco LP / Sysco Corp / Western Midstream Partners LP / Williams Companies Inc / Energy Transfer LP / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / ONE Gas Inc / Kinder Morgan Inc / Enbridge Inc / TC Energy Corp / Sinclair Broadcast Group Inc / Plains All American Pipeline LP / Sirius XM Holdings Inc / Charter Communications Inc / Global Payments Inc / Jack Henry & Associates Inc / Netflix Inc / Nexstar Media Group Inc / Delek Logistics Partners LP / ViacomCBS Inc / Discovery Inc / Commvault Systems Inc / Cheniere Energy Partners LP / Pembina Pipeline Corp / Keyera Corp / Cheniere Energy Inc / Gibson Energy Inc / AMC Networks Inc / Angi Inc / Targa Resources Corp / Summit Midstream Partners LP / MPLX LP / PennyMac Financial Services Inc / Fox Corp / Phillips 66 Partners LP / USA Compression Partners LP / Hemisphere Media Group Inc / Crestwood Equity Partners LP / Shell Midstream Partners LP / EnLink Midstream LLC / Crossamerica Partners LP / PBF Logistics LP / Cable One Inc / Zimmer Biomet Holdings Inc / Tegna Inc / IAC/Interactivecorp / Lions Gate Entertainment Corp / Altice USA Inc / Boston Omaha Corp / Hess Midstream LP / Roku Inc / Spotify Technology SA / E W Scripps Co / AVROBIO Inc / Rattler Midstream LP / iHeartMedia Inc / Equitrans Midstream Corp / Oasis Midstream Partners LP / Home Point Capital Inc / Telus International Cda Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">CRL: Broad-Based Growth in Q1; Enhanced Growth Outlook for the Year</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CRL</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Rev Beat, OMs to 20.7% (GM drop down); Material Rev/EPS Raise</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Brief of Charles River Laboratories International Inc conference call, May 04, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, May 04, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First Look at Strong First-Quarter Results; 13% Organic Revenue Growth and Lower Tax Rate Drive Beat and Guidance Raise</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CRL: 1Q EPS Ahead; Encouraging 2021 Guide Raise on Unprecedented Demand Trends</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for CRL</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International climbs 9.8% from 2 week low</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Peer Group Analytics - Q4 FY2020</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Higher for Life Sciences (1H April); Highlighting ALGN and LH</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ALGN.OQ / LH.N / WAT.N / DGX.N / DHR.N / MTD.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Align Technology Inc / Laboratory Corporation of America Holdings / Waters Corp / Quest Diagnostics Inc / Danaher Corp / Mettler-Toledo International Inc / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eight-bagger Charles River Laboratories International soars 146%</td><td class="leftalignment">English</td><td class="rightalignment">78</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQV: Diagnosing 1Q; The Momentum Continues; Vision '22 Upside; Positive CRO Bankshots</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">IQV.N / DGX.N / LH.N / CRL.N / ICLR.OQ / MEDP.OQ / SYNH.OQ / CERT.OQ</td><td class="leftalignment">IQVIA Holdings Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / Charles River Laboratories International Inc / ICON PLC / Medpace Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Carel Industries advances 59% in past year</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Contract Research Organizations: CRO Commotion Continues: PAREXEL on the Block?</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">IQV.N / SYNH.OQ / CRL.N / ICLR.OQ / MEDP.OQ</td><td class="leftalignment">IQVIA Holdings Inc / Syneos Health Inc / Charles River Laboratories International Inc / ICON PLC / Medpace Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Life Science & Diagnostics : 1Q21 Preview: Base Business Recovery, COVID Tailwinds, 2022+ Outlook and M&A Remain In Focus</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">A.N / ADPT.O / TMO.N / WAT.N / DGX.N / DHR.N / ICLR.O / LH.N / MTD.N / XRAY.O / PKI.N / MYGN.O / ILMN.O / ISRG.O / CRL.N / OSUR.O / HOLX.O / RGEN.O / QDEL.O / BRKR.O / QGEN.N / PACB.O / AXDX.O / NSTG.O / CTLT.N / NVTA.N / NTRA.O / IQV.N / QTRX.O / SYNH.O / GH.O / TWST.O / AVTR.N / NVST.N / TXG.O / BLI.O / RNLX.O / SHC.O / SEER.O / OCDX.O / TLIS.O</td><td class="leftalignment">Agilent Technologies Inc / Adaptive Biotechnologies Corp / Thermo Fisher Scientific Inc / Waters Corp / Quest Diagnostics Inc / Danaher Corp / ICON PLC / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / DENTSPLY SIRONA Inc / PerkinElmer Inc / Myriad Genetics Inc / Illumina Inc / Intuitive Surgical Inc / Charles River Laboratories International Inc / OraSure Technologies Inc / Hologic Inc / Repligen Corp / Quidel Corp / Bruker Corp / Qiagen NV / Pacific Biosciences of California Inc / Accelerate Diagnostics Inc / NanoString Technologies Inc / Catalent Inc / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Quanterix Corp / Syneos Health Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Envista Holdings Corp / 10X Genomics Inc / Berkeley Lights Inc / Renalytix PLC / Sotera Health Co / Seer Inc / Ortho Clinical Diagnostics Holdings PLC / Talis Biomedical Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MISCELLANEOUS / SMALL CAPITAL / TRADING / PORTFOLIO STRATEGY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tycho W. Peterson / Julia Qin / Ms. Eleni M. Apostolatos / Mr. Casey Woodring</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Contract Research Organizations  : State of the CRO Industry: Robust Biotech Funding; CT.gov Analysis; Highlighting CRO Deal Activity</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">PFE.N / TMO.N / DGX.N / LH.N / LONN.S / WST.N / CRL.N / ICLR.OQ / CTLT.N / MEDP.OQ / IQV.N / SYNH.OQ / CERT.OQ</td><td class="leftalignment">Pfizer Inc / Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Tech Hardware - SemiCap Equipment: Firing all cylinders</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">ASMI.AS / ASML.AS / A.N / SOLB.BR / TMO.N / ROG.S / NOVOB.CO / LONN.S / BANB.S / CRL.N / SFZN.S / 068270.KS / CTLT.N / 207940.KS / 2269.HK</td><td class="leftalignment">ASM International NV / ASML Holding NV / Agilent Technologies Inc / Solvay SA / Thermo Fisher Scientific Inc / Roche Holding AG / Novo Nordisk A/S / Lonza Group AG / Bachem Holding AG / Charles River Laboratories International Inc / Siegfried Holding AG / Celltrion Inc / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Denmark / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Chemicals / Healthcare / Industrial Materials / Info. Tech./Computers / Pharmaceuticals / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Achal Sultania / Mr. Achal Sultania / Mr. Patrick Chan</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">TMO: Hello CRO (Pt. 2): Digging Deeper into the PPD Acquisition</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">TMO.N / DGX.N / LH.N / LONN.S / WST.N / CRL.N / ICLR.OQ / CTLT.N / MEDP.OQ / IQV.N / SYNH.OQ / CERT.OQ</td><td class="leftalignment">Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">WEBINAR REPLAY - 1Q'21 Healthcare Tech & Distribution Webinar</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US03073E1055 / IE0005711209 / US1266501006 / US14149Y1082 / US1567821046 / US1598641074 / US58155Q1031 / US7677541044 / US8064071025 / US0162551016 / US7033951036 / US28238P1093 / US9314271084 / US87918A1051 / US24906P1093 / US46266C1053 / US87166B1026 / US29415F1049 / US68269G1076 / US8163073005 / US67181A1079 / GOCO US</td><td class="leftalignment">Amerisourcebergen Corp / ICON PLC / CVS Health Corp / Cardinal Health Inc / Cerner Corp / Charles River Laboratories International Inc / Mckesson Corp / Rite Aid Corp / Henry Schein Inc / Align Technology Inc / Patterson Companies Inc / eHealth Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / DENTSPLY SIRONA Inc / IQVIA Holdings Inc / Syneos Health Inc / Envista Holdings Corp / 1Life Healthcare Inc / SelectQuote Inc / Oak Street Health Inc / Gohealth Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">TMO: Hello CRO? Assessing Theorized PPD Bid</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">TMO.N / DGX.N / LH.N / LONN.S / WST.N / CRL.N / ICLR.OQ / CTLT.N / MEDP.OQ / IQV.N / SYNH.OQ / CERT.OQ</td><td class="leftalignment">Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">CRO Industry Update: Results From Spring 2021 Survey of Biopharmaceutical Sponsors</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">159864107 / 14880610 / G4705A100 / 58506Q109 / 46266C105 / 87166B102</td><td class="leftalignment">Charles River Laboratories International Inc / Catalent Inc / ICON PLC / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">John C. Kreger, III</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">1Q Healthcare Tech & Distribution Preview + 10am Webinar: The Reopening</td><td class="leftalignment">English</td><td class="rightalignment">84</td><td class="leftalignment">US68269G1076 / IE0005711209 / US1266501006 / US14149Y1082 / US1567821046 / US1598641074 / US58155Q1031 / US7677541044 / US8064071025 / US0162551016 / US03073E1055 / US7033951036 / US28238P1093 / US9314271084 / US87918A1051 / US24906P1093 / US46266C1053 / US87166B1026 / US29415F1049 / US8163073005 / US67181A1079 / GOCO US</td><td class="leftalignment">1Life Healthcare Inc / ICON PLC / CVS Health Corp / Cardinal Health Inc / Cerner Corp / Charles River Laboratories International Inc / Mckesson Corp / Rite Aid Corp / Henry Schein Inc / Align Technology Inc / Amerisourcebergen Corp / Patterson Companies Inc / eHealth Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / DENTSPLY SIRONA Inc / IQVIA Holdings Inc / Syneos Health Inc / Envista Holdings Corp / SelectQuote Inc / Oak Street Health Inc / Gohealth Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">A / AMT / APO / ASH / BIO / BX / CCI / CRL / DGX / DHR / DIS / DLR / DVN / DY / EOG / JNJ / KKR / LH / MGY / MTD / PKI / PXD / RKT / SM / T / TMO / USM / WAT / IRM / ICLR.O / SBAC.O / CONE.O / VZ / ILMN.O / TECH.O / LPI / HOLX.O / BLUE.O / EQIX.O / NFLX.O / BRKR.O / VIAC.O / DISCA.O / CNSL.O / CCOI.O / ZIOP.O / FANG.O / MEIP.O / PFSI.K / FOXA.O / FATE.O / QURE.O / ARES.K / AFMD.O / CYAD.O / TMUS.O / ADAP.O / JNCE.O / UNIT.O / CLLS.O / HLNE.O / ZYME.K / IOVA.O / SWCH.K / IQV / QGEN.K / AUTL.O / AVTR.K / PGEN.O / LUMN.K / GHLD.K / GRCL.O / HMPT.O</td><td class="leftalignment">Agilent Technologies Inc / American Tower Corp / Apollo Global Management Inc / Ashland Global Holdings Inc / Bio Rad Laboratories Inc / Blackstone Inc / Crown Castle International Corp / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Walt Disney Co / Digital Realty Trust Inc / Devon Energy Corp / Dycom Industries Inc / EOG Resources Inc / Johnson & Johnson / KKR & Co Inc / Laboratory Corporation of America Holdings / Magnolia Oil & Gas Corp / Mettler-Toledo International Inc / PerkinElmer Inc / Pioneer Natural Resources Co / Rocket Companies Inc / SM Energy Co / AT&T Inc / Thermo Fisher Scientific Inc / United States Cellular Corp / Waters Corp / Iron Mountain Inc / ICON PLC / SBA Communications Corp / CyrusOne Inc / Verizon Communications Inc / Illumina Inc / Bio-Techne Corp / Laredo Petroleum Inc / Hologic Inc / bluebird bio Inc / Equinix Inc / Netflix Inc / Bruker Corp / ViacomCBS Inc / Discovery Inc / Consolidated Communications Holdings Inc / Cogent Communications Holdings Inc / ZIOPHARM Oncology Inc / Diamondback Energy Inc / MEI Pharma Inc / PennyMac Financial Services Inc / Fox Corp / Fate Therapeutics Inc / Uniqure NV / Ares Management Corp / Affimed NV / Celyad Oncology SA / T-Mobile US Inc / Adaptimmune Therapeutics PLC / Jounce Therapeutics Inc / Uniti Group Inc / Cellectis SA / Hamilton Lane Inc / Zymeworks Inc / Iovance Biotherapeutics Inc / Switch Inc / IQVIA Holdings Inc / Qiagen NV / Autolus Therapeutics PLC / Avantor Inc / Precigen Inc / Lumen Technologies Inc / Guild Holdings Co / Gracell Biotechnologies Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Higher for Life Sciences (2H March); Highlighting NVST and AVTR</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">WAT.N / DGX.N / DHR.N / LH.N / MTD.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / ALGN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Align Technology Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">1Q21 Preview: Core Strength Expected; Eyes on the COVID Guide, See Divergence</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / ICLR.O / ILMN.O / TECH.O / HOLX.O / BRKR.O / IQV / QGEN.K / AVTR.K</td><td class="leftalignment">Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Bruker Corp / IQVIA Holdings Inc / Qiagen NV / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/02/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Will Charles River Laboratories International Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">HC Policy – Sizing Impact of Proposed Corporate Tax Hike</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US03073E1055 / IE0005711209 / US1266501006 / US14149Y1082 / US1567821046 / US1598641074 / US4448591028 / US50540R4092 / US58155Q1031 / US74834L1008 / US7677541044 / US8064071025 / US91324P1021 / US0162551016 / US1255091092 / US7033951036 / US15135B1017 / US28238P1093 / US40412C1018 / US0367521038 / US9314271084 / US87918A1051 / US24906P1093 / US46266C1053 / US87166B1026 / US29415F1049 / US68269G1076 / US8163073005 / US67181A1079 / GOCO US</td><td class="leftalignment">Amerisourcebergen Corp / ICON PLC / CVS Health Corp / Cardinal Health Inc / Cerner Corp / Charles River Laboratories International Inc / Humana Inc / Laboratory Corporation of America Holdings / Mckesson Corp / Quest Diagnostics Inc / Rite Aid Corp / Henry Schein Inc / UnitedHealth Group Inc / Align Technology Inc / Cigna Corp / Patterson Companies Inc / Centene Corp / eHealth Inc / HCA Healthcare Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / DENTSPLY SIRONA Inc / IQVIA Holdings Inc / Syneos Health Inc / Envista Holdings Corp / 1Life Healthcare Inc / SelectQuote Inc / Oak Street Health Inc / Gohealth Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">ECONOMIC REPORTS / INDUSTRY REPORTS</td><td class="leftalignment">Michael Newshel / Ms. Elizabeth Anderson</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Comet Resources Limited</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eleven-bagger Creightons soars 82% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Charles River Laboratories International climbs 16% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International climbs 16% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Equity Quarterly Update - Comet Resources crashes 74% in 3 years</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Charles River Laboratories International, Inc. MARCH 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">A / ACN / AR / AZO / BBY / BIO / CNX / COG / CP / CRL / DGX / DHR / DVN / EOG / EQT / FND / GBX / HD / HIG / LH / LOW / MRO / MTD / PKI / PXD / TMO / TRN / WAB / WAT / AMZN.O / ICLR.O / SBAC.O / ILMN.O / TECH.O / CTSH.O / TSCO.O / HOLX.O / PROG.O / BLUE.O / ORLY.O / EQIX.O / BRKR.O / EPAM.K / GATX.K / CDEV.O / CVNA.K / IQV / EYE.O / QGEN.K / AVTR.K / CHWY.K / VRM.O / OSCR.N</td><td class="leftalignment">Agilent Technologies Inc / Accenture PLC / Antero Resources Corp / Autozone Inc / Best Buy Co Inc / Bio Rad Laboratories Inc / CNX Resources Corp / Coterra Energy Inc / Canadian Pacific Railway Ltd / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Devon Energy Corp / EOG Resources Inc / EQT Corp / Floor & Decor Holdings Inc / Greenbrier Companies Inc / Home Depot Inc / Hartford Financial Services Group Inc / Laboratory Corporation of America Holdings / Lowe's Companies Inc / Marathon Oil Corp / Mettler-Toledo International Inc / PerkinElmer Inc / Pioneer Natural Resources Co / Thermo Fisher Scientific Inc / Trinity Industries Inc / Westinghouse Air Brake Technologies Corp / Waters Corp / Amazon.com Inc / ICON PLC / SBA Communications Corp / Illumina Inc / Bio-Techne Corp / Cognizant Technology Solutions Corp / Tractor Supply Co / Hologic Inc / Progenity Inc / bluebird bio Inc / O'Reilly Automotive Inc / Equinix Inc / Bruker Corp / Epam Systems Inc / GATX Corp / Centennial Resource Development Inc / Carvana Co / IQVIA Holdings Inc / National Vision Holdings Inc / Qiagen NV / Avantor Inc / Chewy Inc / Vroom Inc / Oscar Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Could Amazon Disrupt the Clinical Lab Industry?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMZN.OQ / A / BIO / CRL / DGX / DHR / LH / MTD / PKI / TMO / WAT / AMZN.O / ICLR.O / ILMN.O / TECH.O / HOLX.O / PROG.O / BRKR.O / IQV / QGEN.K / AVTR.K</td><td class="leftalignment">Amazon.com Inc / Agilent Technologies Inc / Bio Rad Laboratories Inc / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Waters Corp / Amazon.com Inc / ICON PLC / Illumina Inc / Bio-Techne Corp / Hologic Inc / Progenity Inc / Bruker Corp / IQVIA Holdings Inc / Qiagen NV / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">A / AAP / ABT / ACN / ALC / AMT / ATO / AZO / BAX / BBY / BDX / BIO / BKR / BSX / CCI / CMG / CNP / COO / CRL / DG / DGX / DHR / DLR / DRI / DY / EXR / FND / FTI / GBX / GPS / HAL / HD / HP / HTA / JNJ / LH / LOW / MCD / MDT / MTD / NBR / NEX / NKE / NOV / OII / PEN / PKI / RES / RH / RIG / RKT / RL / SLB / SOI / SPB / SYK / SYY / T / TAP.N / TFX / TMO / TPR / TRN / USM / VFC / W / WAB / WAT / WMT / WSM / AMZN.O / EW / IRM / OGS / OIS / ICLR.O / BBBY.O / SBAC.O / CONE.O / LBRT.N / SGMO.O / IART.O / VZ / SBUX.O / ROST.O / DLTR.O / ILMN.O / TECH.O / CTSH.O / ISRG.O / DXC / PTEN.O / CAKE.O / TSCO.O / HOLX.O / PROG.O / BLUE.O / MMSI.O / ORLY.O / EQIX.O / WOOF.O / BRKR.O / NUVA.O / DXCM.O / CNSL.O / CCOI.O / PODD.O / TNDM.OQ / MRNA.O / ZIOP.O / LUNG.O / ADSGn.DE / EPAM.K / FIVE.O / GMED.K / PFSI.K / MAR.O / FATE.O / NVRO.K / TCON.O / GKOS.K / WING.O / ZBH / CYAD.O / SPNE.O / OLLI.O / PFGC.K / NVCR.O / TMUS.O / ADAP.O / EDIT.O / NTLA.O / GATX.K / USFD.K / CRSP.O / UAA / JNCE.O / UNIT.O / CLLS.O / PUMP.K / NCSM.O / CVNA.K / IOVA.O / SWCH.K / IQV / EYE.O / WTTR.K / QGEN.K / NINE.N / INSP.K / AUTL.O / AXNX.O / CPRI.K / SWAV.O / TPTX.O / AVTR.K / PGEN.O / BEAM.O / VRM.O / NARI.O / LUMN.K / SFT.O / EAR.O / GHLD.K / CHX.O / GRCL.O / HMPT.O / 87975H100</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Abbott Laboratories / Accenture PLC / Alcon AG / American Tower Corp / Atmos Energy Corp / Autozone Inc / Baxter International Inc / Best Buy Co Inc / Becton Dickinson and Co / Bio Rad Laboratories Inc / Baker Hughes Co / Boston Scientific Corp / Crown Castle International Corp / Chipotle Mexican Grill Inc / CenterPoint Energy Inc / Cooper Companies Inc / Charles River Laboratories International Inc / Dollar General Corp / Quest Diagnostics Inc / Danaher Corp / Digital Realty Trust Inc / Darden Restaurants Inc / Dycom Industries Inc / Extra Space Storage Inc / Floor & Decor Holdings Inc / TechnipFMC PLC / Greenbrier Companies Inc / Gap Inc / Halliburton Co / Home Depot Inc / Helmerich and Payne Inc / Healthcare Trust Of America Inc / Johnson & Johnson / Laboratory Corporation of America Holdings / Lowe's Companies Inc / McDonald's Corp / Medtronic PLC / Mettler-Toledo International Inc / Nabors Industries Ltd / Nextier Oilfield Solutions Inc / Nike Inc / Nov Inc / Oceaneering International Inc / Penumbra Inc / PerkinElmer Inc / RPC Inc / RH / Transocean Ltd / Rocket Companies Inc / Ralph Lauren Corp / Schlumberger NV / Solaris Oilfield Infrastructure Inc / Spectrum Brands Holdings Inc / Stryker Corp / Sysco Corp / AT&T Inc / Molson Coors Beverage Co / Teleflex Inc / Thermo Fisher Scientific Inc / Tapestry Inc / Trinity Industries Inc / United States Cellular Corp / VF Corp / Wayfair Inc / Westinghouse Air Brake Technologies Corp / Waters Corp / Walmart Inc / Williams-Sonoma Inc / Amazon.com Inc / Edwards Lifesciences Corp / Iron Mountain Inc / ONE Gas Inc / Oil States International Inc / ICON PLC / Bed Bath & Beyond Inc / SBA Communications Corp / CyrusOne Inc / Liberty Oilfield Services Inc / Sangamo Therapeutics Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Starbucks Corp / Ross Stores Inc / Dollar Tree Inc / Illumina Inc / Bio-Techne Corp / Cognizant Technology Solutions Corp / Intuitive Surgical Inc / DXC Technology Co / Patterson-UTI Energy Inc / Cheesecake Factory Inc / Tractor Supply Co / Hologic Inc / Progenity Inc / bluebird bio Inc / Merit Medical Systems Inc / O'Reilly Automotive Inc / Equinix Inc / Petco Health and Wellness Company Inc / Bruker Corp / NuVasive Inc / Dexcom Inc / Consolidated Communications Holdings Inc / Cogent Communications Holdings Inc / Insulet Corp / Tandem Diabetes Care Inc / Moderna Inc / ZIOPHARM Oncology Inc / Pulmonx Corp / Adidas AG / Epam Systems Inc / Five Below Inc / Globus Medical Inc / PennyMac Financial Services Inc / Marriott International Inc / Fate Therapeutics Inc / Nevro Corp / TRACON Pharmaceuticals Inc / Glaukos Corp / Wingstop Inc / Zimmer Biomet Holdings Inc / Celyad Oncology SA / SeaSpine Holdings Corp / Ollie's Bargain Outlet Holdings Inc / Performance Food Group Co / Novocure Ltd / T-Mobile US Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Intellia Therapeutics Inc / GATX Corp / US Foods Holding Corp / CRISPR Therapeutics AG / Under Armour Inc / Jounce Therapeutics Inc / Uniti Group Inc / Cellectis SA / ProPetro Holding Corp / NCS Multistage Holdings Inc / Carvana Co / Iovance Biotherapeutics Inc / Switch Inc / IQVIA Holdings Inc / National Vision Holdings Inc / Select Energy Services Inc / Qiagen NV / Nine Energy Service Inc / Inspire Medical Systems Inc / Autolus Therapeutics PLC / Axonics Inc / Capri Holdings Ltd / Shockwave Medical Inc / Turning Point Therapeutics Inc / Avantor Inc / Precigen Inc / Beam Therapeutics Inc / Vroom Inc / Inari Medical Inc / Lumen Technologies Inc / Shift Technologies Inc / Eargo Inc / Guild Holdings Co / ChampionX Corp / Gracell Biotechnologies Inc / Home Point Capital Inc / Telus International Cda Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Charles River Laboratories International Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Creightons PLC</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Higher for Life Sciences (1H March); Highlighting LH and MEDP</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">WAT.N / DGX.N / DHR.N / LH.N / MTD.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / ALGN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / OCDX.OQ</td><td class="leftalignment">Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Align Technology Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LH: Activists at Work; Strategic Review Underway; Our Latest SOTP Analysis</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">LH.N / DGX.N / LONN.S / WST.N / CRL.N / ICLR.OQ / CTLT.N / MEDP.OQ / IQV.N / SYNH.OQ / PDD.OQ</td><td class="leftalignment">Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc / Pinduoduo Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BANB.S: Bachem Holding - Set up for strong FY21/22 growth</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BANB.S / A.N / TMO.N / LONN.S / CRL.N / SFZN.S / 068270.KS / CTLT.N / 207940.KS / 2269.HK</td><td class="leftalignment">Bachem Holding AG / Agilent Technologies Inc / Thermo Fisher Scientific Inc / Lonza Group AG / Charles River Laboratories International Inc / Siegfried Holding AG / Celltrion Inc / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr. Christoph Gretler / Fr. Barbora Blaha</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">185</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Carel Industries in bottom 3% performers of Italian market in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MEDP: On the Virtual Road With Management</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MEDP.OQ / CRL.N / ICLR.OQ / IQV.N / SYNH.OQ</td><td class="leftalignment">Medpace Holdings Inc / Charles River Laboratories International Inc / ICON PLC / IQVIA Holdings Inc / Syneos Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ULVR-GB -  Dividend Quality Analysis, for the period ended November 20,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ULVR.L / ABF.L / MCB.L / PFD.L / PZC.L / CRGT.L</td><td class="leftalignment">Unilever PLC / Associated British Foods PLC / McBride PLC / Premier Foods PLC / PZ Cussons PLC / Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Mar. 10, 2021 / 10:20AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ICLR-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ICLR.O / CRL / BASI.O / SCYX.O</td><td class="leftalignment">ICON PLC / Charles River Laboratories International Inc / Inotiv Inc / SCYNEXIS Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Higher for Life Sciences (2H Feb); Highlighting ICLR and ELAN</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ELAN.N / ICLR.OQ / WAT.N / DGX.N / DHR.N / LH.N / MTD.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / ALGN.OQ / BRKR.OQ / PETS.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Elanco Animal Health Inc / ICON PLC / Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Align Technology Inc / Bruker Corp / Petmed Express Inc / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International sinks 10.8% from 3 week high</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools & Diagnostics: Top Questions for Management Teams</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">4502.T / BMY.N / CI.N / CVS.N / GE.N / JPM.N / MCK.N / MRK.N / PFE.N / TMO.N / WMT.N / DGX.N / AZN.L / ROG.S / DHR.N / UNH.N / LH.N / MMM.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / AMZN.OQ / ALGN.OQ / STMN.S / PETS.OQ / ICLR.OQ / QGEN.N / BAYGN.DE / ZTS.N / PAHC.OQ / LNTH.OQ / ANTM.N / WBA.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / General Electric Co / JPMorgan Chase & Co / Mckesson Corp / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Walmart Inc / Quest Diagnostics Inc / AstraZeneca PLC / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / 3M Co / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Amazon.com Inc / Align Technology Inc / Straumann Holding AG / Petmed Express Inc / ICON PLC / Qiagen NV / Bayer AG / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Ireland / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for CRL. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Comet Resources adds 24% in past year</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Cash Conversion Cycle 2010-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Information Content of Earnings Releases 2015-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Charles River Laboratories International Net Profit up 44.6%</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Carel Industries SpA</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment"></td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Charles River Laboratories International Net Profit up 44.6%</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRVI: 4Q Preview; Highlighting Relevant COVID-19 Vaccine Updates</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRVI.OQ / PFE.N / TMO.N / CRL.N / BAYGN.DE / CTLT.N / CVAC.OQ</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Charles River Laboratories International Inc / Bayer AG / Catalent Inc / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Creightons PLC Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Agriculture / Beverages & Tobacco / Consumer / Cosmetics & Personal Care / Food / Household Products / Retailing / Services</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Ownership Timelines & Shareholder Analytics (February 2021)</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SFZN.S: Siegfried Holg - Set up for a strong FY21; reiterate Outperform with increased target price of SFr800</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">SFZN.S / TMO.N / LONN.S / BANB.S / CRL.N / CTLT.N / 2269.HK</td><td class="leftalignment">Siegfried Holding AG / Thermo Fisher Scientific Inc / Lonza Group AG / Bachem Holding AG / Charles River Laboratories International Inc / Catalent Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr. Christoph Gretler / Fr. Barbora Blaha</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Contract Research Organizations: ICLR + PRAH - CRO Mega Merger Ruminations; Recapping 4Q EPS Reports</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ICLR.OQ / DGX.N / LH.N / LONN.S / WST.N / CRL.N / CTLT.N / MEDP.OQ / IQV.N / SYNH.OQ / CERT.OQ</td><td class="leftalignment">ICON PLC / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / Catalent Inc / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Lower for Life Sciences (1H Feb); Highlighting MRVI and ALGN</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">WAT.N / DGX.N / DHR.N / LH.N / MTD.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / ALGN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ</td><td class="leftalignment">Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Align Technology Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Healthcare IT & Distribution: Cell & Gene Therapy Takes Center Stage: CRL and CTLT Announce Acquisitions</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CRL.N / CTLT.N</td><td class="leftalignment">Charles River Laboratories International Inc / Catalent Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">George R. Hill / Charlotte Kolb / Maxi Ma</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Annual Update - Charles River Laboratories International down 6.9% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CRL-US Company reports financial results for the quarter ended December 26,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CRL / RGEN.O / BASI.O / SCYX.O</td><td class="leftalignment">Charles River Laboratories International Inc / Repligen Corp / Inotiv Inc / SCYNEXIS Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Charles River Laboratories International advances 25% in past quarter, CEO James C. Foster sells</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Charles River Laboratories International up 6.9% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AN=US / ADI=US / DVN=US / PEB=US / H=US / CONE=US / MTN=US / CRK=US / ENR=US / PB=US / MAR=US / TNL=US / VMC=US / HLT=US / TOL=US / MLM=US / FUN=US / CRL=US / CHH=US / CYH=US / DHI=US / DRH=US / EQT=US / KBH=US / LEN=US / PHM=US / SHOP=US / SKY=US / WIX=US / HTH=US / CVX=US / BXS=US / MANT=US / ABCB=US / VNO=US / RF=US / PNFP=US / JRVR=US / NOMD=US / KAR=US / SHO=US / BAH=US / RNST=US / HST=US / RPRX=US / OC=US / CADE=US / EIG=US / IAA=US / WH=US / JACK=US / AR=US / HGV=US / NXPI=US / RLJ=US / VAC=US / BCEI=US / GMED=US / RHP=US / IBTX=US / VCYT=US / QTWO=US / WK=US / SEDG=US / WING=US / PK=US / PLYA=US / ROKU=US / SWCH=US / EQH=US / UBER=US / OVV=US</td><td class="leftalignment">AutoNation Inc / Analog Devices Inc / Devon Energy Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / CyrusOne Inc / Vail Resorts Inc / Comstock Resources Inc / Energizer Holdings Inc / Prosperity Bancshares Inc / Marriott International Inc / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Toll Brothers Inc / Martin Marietta Materials Inc / Cedar Fair LP / Charles River Laboratories International Inc / Choice Hotels International Inc / Community Health Systems Inc / D R Horton Inc / Diamondrock Hospitality Co / EQT Corp / KB Home / Lennar Corp / Pultegroup Inc / Shopify Inc / Skyline Champion Corp / Wix.Com Ltd / Hilltop Holdings Inc / Chevron Corp / Cadence Bank / ManTech International Corp / Ameris Bancorp / Vornado Realty Trust / Regions Financial Corp / Pinnacle Financial Partners Inc / James River Group Holdings Ltd / Nomad Foods Ltd / KAR Auction Services Inc / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / Renasant Corp / Host Hotels & Resorts Inc / Royalty Pharma PLC / Owens Corning / Cadence Bank / Employers Holdings Inc / IAA Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Antero Resources Corp / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Independent Bank Group Inc / Veracyte Inc / Q2 Holdings Inc / Workiva Inc / Solaredge Technologies Inc / Wingstop Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Roku Inc / Switch Inc / Equitable Holdings Inc / Uber Technologies Inc / Ovintiv Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Not a chocolate factory, but still a sweet end to the year; PT to $324</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CRL=US</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alexander Y. Draper, CFA / Mr. Stan Berenshteyn / Mitchell Ostrovsky</td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Charles River Laboratories: The Leading Edge: CRL Delivers Q4 Beat, Solid F21 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">George R. Hill / Charlotte Kolb / Maxi Ma</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Carl Data Solutions Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Electronics / Info. Tech./Software / Technology</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Post-Call Model Adjustments; Increasing Estimates Following Initial 2021 Guidance and Cognate Bio Purchase</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Further Upside Not Much of a 'Cognat'ive Leap</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AR / BAC / BAX / CLR / CNX / COG / CRL / DG / DVN / EOG / EQR / EQT / MRO / PNC / RKT / RRC / SM / STZ / SWN / USB / WAL / DLTR.O / EMA.TO / DOL.TO / STX.O / WDC.O / FIVE.O / FANG.O / PFSI.K / PBFX.K / WING.O / OLLI.O / KREF.K / GHLD.K / CHK.O</td><td class="leftalignment">Antero Resources Corp / Bank of America Corp / Baxter International Inc / Continental Resources Inc / CNX Resources Corp / Coterra Energy Inc / Charles River Laboratories International Inc / Dollar General Corp / Devon Energy Corp / EOG Resources Inc / Equity Residential / EQT Corp / Marathon Oil Corp / PNC Financial Services Group Inc / Rocket Companies Inc / Range Resources Corp / SM Energy Co / Constellation Brands Inc / Southwestern Energy Co / US Bancorp / Western Alliance Bancorp / Dollar Tree Inc / Emera Inc / Dollarama Inc / Seagate Technology Holdings PLC / Western Digital Corp / Five Below Inc / Diamondback Energy Inc / PennyMac Financial Services Inc / PBF Logistics LP / Wingstop Inc / Ollie's Bargain Outlet Holdings Inc / KKR Real Estate Finance Trust Inc / Guild Holdings Co / Chesapeake Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Charles River Laboratories : 4Q20 Recap: Broad-Based Strength w/ Cognate Tuck-In Expanding Footprint into C&GT CDMO Space; Reiterate OW, PT to $325</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MISCELLANEOUS / CHANGE IN RECOMMENDATION / EVENT CALENDAR / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tycho W. Peterson / Ms. Eleni M. Apostolatos / Julia Qin / Mr. Casey Woodring</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">CRL: Positive Outlook; Like the Cognate Deal with More Cell/Gene Therapy Exposure</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CRL</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Dan L. Leonard / Timothy Daley / Lu Li</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Acquires CDMO Cognate (25-30c acc to ’22); 4Q Rev/EPS Beats; FY21 Guide Above</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US1598641074</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Elizabeth Anderson</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First Look at Fourth-Quarter Results; 10% Organic Growth Drives Beat and Cognate Purchase Boosts Bet on Cell & Gene Therapy</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">159864107</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John C. Kreger, III</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Brief of Charles River Laboratories International Inc conference call, Feb. 17, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">CRL.N - Event Transcript of Charles River Laboratories International Inc conference call, Feb. 17, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CRL: 4Q EPS Ahead; Unveils Encouraging '21 Guide; CDMO Deal Materializes</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/13/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Carl Data Solutions Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">CRL.CD</td><td class="leftalignment">Carl Data Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for CRL</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQV: Diagnosing 4Q; TAS and RDS Momentum; Positive CRO Bankshots</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">IQV.N / DGX.N / AZN.L / ROG.S / NOVOB.CO / LH.N / LONN.S / WST.N / CRL.N / ICLR.OQ / CTLT.N / MEDP.OQ / SYNH.OQ / CERT.OQ</td><td class="leftalignment">IQVIA Holdings Inc / Quest Diagnostics Inc / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Laboratory Corporation of America Holdings / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Lower for Life Sciences (2H Jan); Highlighting IDXX and TMO</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">A.N / BDX.N / TMO.N / WAT.N / DGX.N / DHR.N / LH.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / ILMN.OQ / ALGN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ</td><td class="leftalignment">Agilent Technologies Inc / Becton Dickinson and Co / Thermo Fisher Scientific Inc / Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Illumina Inc / Align Technology Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Charles River Laboratories International Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Comet Resources falls for a third consecutive year, a three-year fall of 79%</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CRL.AX</td><td class="leftalignment">Comet Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Carel Industries accelerates rise, up 80% in 2 years</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CRLI.MI</td><td class="leftalignment">Carel Industries SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PZC-GB Company reports financial results for the half-year ended November 30,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PZC.L / MCB.L / PFD.L / ULVR.L / CRGT.L</td><td class="leftalignment">PZ Cussons PLC / McBride PLC / Premier Foods PLC / Unilever PLC / Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools and Diagnostics: Short Interest Lower for Life Sciences (1H Jan); Highlighting ZTS and ALGN</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">WAT.N / DGX.N / DHR.N / LH.N / MTD.N / PKI.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / ALGN.OQ / BRKR.OQ / PETS.OQ / ICLR.OQ / ZTS.N / PAHC.OQ / LNTH.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ</td><td class="leftalignment">Waters Corp / Quest Diagnostics Inc / Danaher Corp / Laboratory Corporation of America Holdings / Mettler-Toledo International Inc / PerkinElmer Inc / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Align Technology Inc / Bruker Corp / Petmed Express Inc / ICON PLC / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for CRL.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRL.N</td><td class="leftalignment">Charles River Laboratories International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Creightons PLC Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CRGT.L</td><td class="leftalignment">Creightons PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Agriculture / Beverages & Tobacco / Consumer / Cosmetics & Personal Care / Food / Household Products / Retailing / Services</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Life Sciences Tools and Dx : Final Takeaways from J.P. Morgan Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">ADPT.O / TMO.N / WAT.N / DHR.N / MTD.N / XRAY.O / MYGN.O / ILMN.O / ISRG.O / CRL.N / OSUR.O / HOLX.O / QDEL.O / BRKR.O / QGEN.N / PACB.O / AXDX.O / NSTG.O / CTLT.N / NVTA.N / NTRA.O / IQV.N / SYNH.O / GH.O / TWST.O / AVTR.N / NVST.N / TXG.O / BLI.O / RNLX.O / SHC.O / SEER.O</td><td class="leftalignment">Adaptive Biotechnologies Corp / Thermo Fisher Scientific Inc / Waters Corp / Danaher Corp / Mettler-Toledo International Inc / DENTSPLY SIRONA Inc / Myriad Genetics Inc / Illumina Inc / Intuitive Surgical Inc / Charles River Laboratories International Inc / OraSure Technologies Inc / Hologic Inc / Quidel Corp / Bruker Corp / Qiagen NV / Pacific Biosciences of California Inc / Accelerate Diagnostics Inc / NanoString Technologies Inc / Catalent Inc / Invitae Corp / Natera Inc / IQVIA Holdings Inc / Syneos Health Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Envista Holdings Corp / 10X Genomics Inc / Berkeley Lights Inc / Renalytix PLC / Sotera Health Co / Seer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / CAPITALIZATION / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / SMALL CAPITAL / EVENT CALENDAR / MORNING COMMENTS / TRADING / GROWTH</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tycho W. Peterson / Julia Qin / Ms. Eleni M. Apostolatos / Mr. Casey Woodring</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">CRO 2020 Year End Wrap-up; Key Indicators Point to Robust 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">159864107 / G4705A100 / 58506Q109 / 46266C105 / SYNH</td><td class="leftalignment">Charles River Laboratories International Inc / ICON PLC / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">John C. Kreger, III / Jonathan Kaufman / Courtney Owens</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Contract Research Organizations : State of the CRO Industry: Biotech Funding Remains Robust; CT.gov Analysis</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">PFE.N / DGX.N / LH.N / LONN.S / WST.N / CRL.N / ICLR.OQ / CTLT.N / MEDP.OQ / IQV.N / SYNH.OQ / CERT.OQ</td><td class="leftalignment">Pfizer Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
</tbody></table>
</body>
</html>